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ABSTRACT
ABSTRACT 
Background
Femoral impaction allografting to reconstitute bone loss during revision hip surgery 
has shown excellent results. However, limitations with the use of allografts have 
warranted research to investigate if bone graft substitutes could be a suitable 
alternative to replace or augment allograft in impaction grafting.
Aims and Methods
The objectives of this thesis were to assess if:
• The use of hydroxyapatite (HA) in various combinations with allograft will be 
biologically effective and functionally stable using a cemented impaction 
grafting technique in an ovine hemiarthroplasty model. The different 
treatment groups were compared by measuring the ground reaction forces and 
new bone formation.
• The addition of mesenchymal stem cells (MSCs) to allograft, HA or an 
allograft:HA mixture enhances the amount of new bone formation compared 
with impaction o f the scaffold alone in an ovine metaphyseal femoral bone 
defect model.
• The architecture of the HA scaffold influences bone formation in an extra- 
skeletal sheep model.
Results
HA: allograft mixture of up to 90:10 demonstrated similar functional stability 
and amount of new bone formation as a 50:50 mixture.
ABSTRACT
• Addition of MSCs to allograft or a 50:50 allograft:HA mixture enhances the 
amount of new bone formation compared with unimpacted constructs.
• HA either alone or combined with MSCs induces bone growth only when 
constructed in block form and not in identical porous granular form.
Conclusion
HA is a suitable bone substitute to augment allograft and may be replace bone graft 
completely in impaction grafting of a femoral component. This has important clinical 
implications as HA is readily available, easy to use in surgery and not associated with 
the adverse effects encountered with allografts. The use of MSCs in the treatment of 
osteolysis holds great potential but further work is required to assess if this 
technology is transferable to humans.
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CHAPTER 1
1.1a Introduction
Total hip replacement (THR) represents the most significant advance in orthopaedic 
surgery in the twentieth century and ranks as one of the most revolutionary advances 
in modem medicine (NICE, 2000). It achieves an immediate and exceptional 
restoration in the quality o f life that is comparable only to angioplastic treatment of 
coronary heart disease (Rasanen et al., 2007). THR is most commonly performed for 
hip joint failure resulting from the arthropathies. Other indications include 
intracapsular hip fractures, avascular necrosis, bone tumours, polio, development 
dysplasia of the hip (DDH) and Paget's disease. Most individuals have an excellent 
prognosis for long-term improvement in symptoms and physical function.
In the United Kingdom there are nearly 60,000 primary total hip arthroplasties being 
performed eaeh year (National Joint Registry, 2008). In the USA, there are more than 
120,000 THR’s performed annually, a 64% increase in the last twenty years (NIH, 
1995). The average hospital cost of a primary THR, in the USA, is estimated to be 
over $11,000 (lorio et al., 1999). In the UK, THR represents a substantial financial 
burden to the NHS of around £140 million per year, with each trust spending over 
£250,000 on the purchase of hip prostheses alone (NICE, 2000). Figures from the 
National Audit Office indicate that the cost o f primary THR procedures in NHS 
Trusts eosts an average of around £3,500 (National Audit Office, 2003).
Over the last two decades, eomplications associated with THR have declined 
significantly (Clohisy et al., 2004). Prophylactic antibiotic therapy has reduced 
infection rates and the use of anticoagulants has lowered the incidence of deep venous 
thrombosis. However, bone loss following a total joint arthroplasty or periprosthetic 
osteolysis still remains a significant concern (Harris, 2001). Bone loss following hip
17
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replacement was identified as the major long-term adverse effect with THR, at the 
NIH Consensus Conference on Total Hip Joint Replacements (NIH, 1995). The 
incidence of periprosthetic osteolysis or aseptic loosening in many studies is greater 
than the sum of all the rest of the complications (Harris, 2001). In the Swedish Total 
Hip Replacement Register, osteolysis accounted for over 75% of the patients 
undergoing revision hip surgery (Malchau et al., 2002).
1.1b Background
The first description of periprosthetic osteolysis was made by Professor Chamley in 
1975, when he observed a “cystic erosion of bone” surrounding a fractured femoral 
component (Chamley and Hailey, 1975). Since then, osteolysis has been extensively 
reported (Zicat et al., 1995; Clohisy and Harris, 1999; Heilman et al., 1999; Dorr et 
al., 1997; Rubash et al., 1998). Both the acetabular and femoral components may be 
affected. The prevalence of aseptic loosening, in most series beyond 10-years, is 
reported to be between 32% and 62%, depending on the type of prosthesis used 
(Elting et al., 1995; Clohisy and Harris, 1999; Heilman et al., 1999; Dorr et al., 1997).
1.1c Histology
Initial reports examining periprosthetic tissues around loosened components were 
noted to contain cement particles (Chamley and Hailey, 1975). These tissues 
displayed a high degree of osteoclastic bone resorption, a high concentration of 
macrophages, and foreign body giant cells with phagocytosed cement particles, 
leading to what was called cement disease. Polyethylene particles were not implicated 
as the cause of osteolysis until cementless components were inserted and 
subsequently noted to have endosteal osteolysis. Particulate polyethylene has been
18
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recovered in significant quantities from periprosthetie tissues and is now considered 
to be responsible for osteolysis, forming the majority of debris volume (Campbell et 
al., 1995; Maloney et al., 1995; Margevicius et al., 1994). Studies of wear debris from 
periprosthetie tissues charaeterised by scanning electron microscopy have 
demonstrated that up to 90 percent of the recovered partieles are submicron ultra- 
high-molecular-eight polyethylene (UHMWPE) partieles, with a mean size of about 
0.5 micrometer (Jacobs et al., 2001). These particles vary in shape, with spheroid 
forms being the most common. Fibrillar and globular shapes are also present (Jacobs 
et al., 2001). Billions of particles per gram of tissue have been found (Jacobs et al.,
2001). As light-microscopy resolution is limited by the wavelength of visible light 
(0.4 to 0.7 mierometer), UHMWPE particles cannot be visualised well with 
conventional histological techniques. The use o f Oil Red ‘O ’ (ORO) staining has 
been shown to be a sensitive and specific marker in identifying UHMWPE partieles 
on histological sections(Hansen et al., 2002; Schmalzried et al., 1993).
The formation of a ‘synovial-like membrane’ between implant and bone is 
fundamental to most theories of aseptic loosening (Goldring et al., 1983). 
Histological analysis of tissue surrounding loosened components (Fig 1.1) after joint 
replacement reveals the presence of three distinct zones: (1) a thin synovial layer of 
lining cells supported by fibro-vascular tissue at the cement surface; (2) a middle 
layer containing histiocytes (tissue macrophages), giant cells, mononuclear cells 
(lymphocytes and mast cells) and periprosthetic particles; and (3) a fibrous layer that 
blends into the marrow spaces between bone. The addition of conditioned media to 
synovial-like membranes, obtained from patients re-operated due to aseptic 
loosening, has been shown to produce macrophages and giant cells that stimulate
19
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bone resorption, in vitro, by an osteoclast-mediated mechanism (Ohlin et al., 1990; 
Athanasou et al., 1992).
Figure 1.1: Histological analysis of tissue surrounding loose components. 
Hyperplastie synovial membrane adjacent to prosthesis-low power (a);
methylmethacralate debris surrounded by giant cells-high power (b) and polyethylene 
flakes (shiny linear material) surrounded by foreign body giant eell reaetion-high 
power (e) and low power (d) (taken from http://www.gentili.net/thr/osteolys.htm).
1.2 Pathogenesis of bone loss following THR
Normal bone maintenance depends on the balance of bone formation and bone 
resorption that mainly involves the coordinated function of osteoblasts and 
osteoclasts. There are several postulated mechanisms by which bone loss after a joint 
replacement may oecur (Rubash et al., 1998).
20
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1.2 a Ageing
Bone loss may occur as a result o f natural ageing. Females can lose up to one-third of 
their cortical bone and half of their trabecular bone throughout their lifetime, whilst 
males lose about half that amount (Rubash et al., 1998). Also, with increasing age, 
bone resorption occurs throughout the skeleton and about one quarter o f total bone 
mineral density is lost in the proximal femur by the age of seventy (Rubash et al., 
1998). However, post-mortem analysis of retrieved femurs in elderly patients treated 
with cemented femoral implants does not show the ageing process to be a major 
threat to the mechanical stability of the implants (Coathup et al., 2001; Jasty et al., 
1990).
1.2b Adaptive bone remodelling or stress shielding
Adaptive bone remodelling or stress shielding can occur in response to an altered 
mechanical environment following a hip replacement. It occurs because there is a 
redistribution of load (and consequently stress on the bone) when the femoral head is 
replaced by the femoral component of a total hip replacement. Consequently, stress 
on the proximal femoral cortex is lessened, as most of the load bypasses this area and 
is transmitted in the metal stem to the distal femur.
Cemented stems are associated with less stress shielding than uncemented stems 
(Huiskes and Boeklagen, 1989; Harris, 1992). This is probably because uncemented 
stems are larger and stiffer than cemented stems and both these factors are known to 
increase stress shielding (Huiskes and Boeklagen, 1989; Rubash et al., 1998). 
Although, bone resorption in unstressed areas has been a frequent finding, it is not 
associated with loosening (NIH, 1995). Studies have shown that fully coated stems
21
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are associated with an increased cortical bone stress shielding compared with 
proximally coated porous stems (Huiskes and Boeklagen, 1989; Weinans et al,,
1994). The amount of coating on most prosthetic stems available today is still greater 
than that necessary to reduce the stress-shielding effect on the proximal femur (NIH,
1995). However, reducing porous coating to lower stress shielding must be balanced 
against providing adequate coating to ensure fixation. Although the long-term effects 
o f stress shielding on the stability of components and further revision surgery are not 
known (Rubash et al., 1998), the lack of good bone stock encountered provides a 
technical challenge for the surgeon.
1.2c Mechanical Factors
Migration of a prosthesis is defined as a change in the position of the prosthesis, 
cement mantle or both and is thought to indicate implant failure and evidence of 
loosening (Harris et al., 1982). The mechanism by which migration occurs is not fully 
understood. Early migration could be attributed to surgical technique (reaming, 
broaching or high pressure pulsatile lavage), which disturbs the capillary circulation 
of the periprosthetic bone, leading to necrosis. Other postulated causes include 
infiltration of loose connective tissue in the process of remodelling and 
revascularisation of the bone graft (Franzen et al., 1995), poor cementing technique 
(Iyer and Krishnan, 2006), fracture of the cement-graft complex (Franzen et al., 1995) 
or distal movement within the cement mantle due to creep of the cement (Fowler et 
al., 1988). Late migration is most likely due to fatigue-failure of cancellous bone 
surrounding the prosthesis (Taylor and Tanner, 1997) leading to loss of 
osteointegration of a stable prosthesis. Once migration has started to occur there is 
then a race between remodelling of the bone around the prosthesis to restore stability
22
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and progressive loosening. It is not fiilly understood why some prostheses remain 
stable whilst others migrate. Once migration has started, stability is lost and 
periprosthetic particles may modulate the later stages of loosening (Aspenberg and 
Herbertsson, 1996). Instability has been shown to lead to the formation of tissue 
similar to fibrous membrane around loosened components (Aspenberg and 
Herbertsson, 1996). Once this process has started periprosthetic particles allow this 
membrane to persist and inhibit new bone formation around it (Aspenberg and 
Herbertsson, 1996).
1.2d Fluid Pressure
Once a synovial-like membrane has been formed, synovial fluid pressure within the 
joint may cause osteolysis in one o f two ways. Firstly, it may contribute to the spread 
of wear debris which directly initiates bone resorption via macrophage activation 
(Aspenberg and Van, V, 1998) (Fig 1.2). Secondly, an elevated fluid pressure itself 
can disturb the normal perfusion and oxygenation o f bone resulting in osteocyte 
destruction and stimulation of macrophages to secrete cytokines that ultimately cause 
bone resorption (Aspenberg and Van, V, 1998; Ferrier et al., 2000; McEvoy et al.,
2002). Synovial fluid pressure can rise up to 700mm Hg during walking, stair 
climbing or rising from a sitting position but pressures as low as 200mm Hg have 
been shown to cause osteolysis (Aspenberg and Van, V, 1998). For this reason some 
authors believe that periprosthetic osteolysis is mainly caused by fluid pressure and to 
a lesser degree by wear particles (Aspenberg and Van, V, 1998).
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Figure 1.2: Schematic representation showing how synovial fluid pressure within the 
hip joint causes osteolysis.
1.2e Particulate Debris
It is now widely accepted that bone loss secondary to a biological reaction to 
particulate debris from implants is the principal mechanism responsible for 
periprosthetic osteolysis (Rubash et ah, 1998). In prosthetic joints, the relevant wear 
mechanisms include adhesion, abrasion and fatigue. The production of submicron 
particles in the hip is mainly caused by abrasive wear (Campbell et al., 1995). From a 
mechanical perspective, implant geometry and material properties are the major
24
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factors influencing the generation of wear debris and the osteolysis that follows (Zhu 
et al., 2001). Joint forces and kinematics, combined with the contact surface 
geometries and material properties, determine the cyclic stresses that lead to particle 
generation (Zhu et al., 2001). Although polyethylene particles are produced in a 
variety of sizes, UHMWPE particles have been identified as the important cause of 
osteolysis (Campbell et al., 1995). An estimated 25,000 to 100 million UHMWPE 
particles are produced and released into the joint space each day (Rubash et al., 
1998).
Other particles that have been implicated in the development of osteolysis include 
polymethylmethacrylate (cement) and metallic debris derived from cobalt and 
titanium alloys, silicates and stainless steel (Jacobs et al., 2001). High concentrations 
of metal ions, derived from prosthetic implants, have been measured in the serum and 
urine of patients who have had hybrid and porous-coated total hip replacements 
(Jacobs et al., 2001). Stem-bone “fretting” may be a cause of this debris, particularly 
in distal portions o f proximally fixed prostheses where considerable movement 
between stem and bone may continue, resulting in loosening of prostheses. The 
metallic particles probably exert their effects by either promoting third body wear of 
the polyethylene, with UHMWPE triggering the cellular response; or they may 
directly accelerate the natural cascade which instigates osteolysis. These metallic 
particles are of particular concern when implants with metal-on-metal bearing 
surfaces or extensively porous-coated devices with large surface areas of exposed 
metal are used. Furthermore, metal-on-metal implants have been shown to release 
high concentrations of metallic ions up to 5 years post surgery (Savarino et al., 2002). 
The long term biological effects of metallic ions are not known, but concerns have 
been raised about hypersensitivity and potential toxic effects, including the ability to
25
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cause malignant transformation (Jacobs et al., 1998). However in 1996, Visuri et al. 
showed no significant increased risk of malignancies 15 years following metal-on- 
metal articulations.
1.2f Migration of Particles
Particulate matter is dispersed in joint fluid. The concept of an effective joint space, 
which includes all periprosthetic regions that are accessible to joint fluid and thus 
particulate debris, has been proposed as the mechanism for migration of particles 
(Schmalzried et al., 1992). The presence of particulate matter in joint fluid will 
initiate a localised macrophage-induced phagocytosis and result in bone resorption. 
As bone is resorbed, a pool is formed, promoting increased flow (preferential flow) 
into that region and thus delivering more particles and causing further localised bone 
resorption. This cycle continues and eventually a significant quantity o f bone 
becomes resorbed to become evident as an osteolytic area on a radiograph. Fluid 
pressure propels joint fluid and thus particulate debris through the effective joint 
space, resulting in progressive bone loss (Schmalzried et al., 1992).
Small particles (0.5-10pm) promote the most severe inflammatory response because 
they are phagocytosable and elevated levels will induce an increased immune 
response (Jacobs et al., 2001). When generated, these small particles will follow a 
route of least resistance and become interposed between the bone/cement interface or 
between the bone/implant interface in uncemented prostheses (Jacobs et al., 2001). In 
cemented femoral components, the path o f least resistance is along the cement-metal 
or cement-bone interface. For example, particles may be driven along the interface 
between the stem and cement and through defects or cracks in the cement mantle and
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provide a route through which the contents of the joint cavity may reach the endosteal 
surface of the femur, leading to localised bone lysis (Anthony et al., 1990). In 
addition, particulate debris is transported away from the joint through the lymphatics 
or urine (Langkamer et al., 1992). The saturation of these systems would result in 
local particle accumulation and further osteolysis could develop.
1.2g Cellular Response to Particles
The cellular response to particles is complex and not completely understood (Jacobs 
et al., 2001). The presence of particulate debris initiates phagocytosis by macrophages 
and macrophage derived foreign-body giant cells. As a consequence, macrophages 
and possibly other cells, including fibroblasts, release cytokines such as tumour 
necrosis factor (TNF-a), interleukins (IL-1, IL-6, IL-10), proteolytic enzymes and 
prostaglandins (PGE2) (Rubash et al., 1998). Osteoblasts may also cause the 
secretion of specific cytokines by activated macrophages (Rubash et al., 1998). These 
intracellular mediators induce a complex cellular response, which initiates a focal 
bone resorptive process mediated primarily by osteoclasts and to a lesser degree by 
monocytes (Rubash et al., 1998).
Analysis of periprosthetic material and experimental models of debris-induced 
osteolysis have implicated osteoclasts as being central to the development of 
osteolysis (Archibeck et al., 2001). The differentiation and function of osteoclasts is 
tightly coupled to osteoblasts and the method o f coupling has been identified as the 
receptor/activator of nuclear factor-K(3, its ligand, and the osteoprotegerin 
(RANK/RANKL/OPG) system (Clohisy, 2003). This system has been directly 
implicated in the development of osteolysis around THRs. In vitro experiments using
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cells retrieved from periprosthetic tissue demonstrated induction o f RANK and 
RANKL mRNA by wear particles (Haynes et al., 2001). Activated cells in the 
interface membrane of failed THRs overproduce both RANKL and RANK (Ohmori 
et al., 2002). The expression of RANK, RANKL, and OPG in the periprosthetic tissue 
of both aseptic and septic loosened THRs has implicated this system as being central 
to the mechanism of bone loss (Gehrke et al., 2003).
1.2h Biological Response to Wear Debris
The presence o f wear debris does not always result in osteolysis. For osteolysis to 
occur, the rate of production of wear particles must exceed an individual’s capacity to 
remove the debris such that a threshold is reached above which the development of 
osteolysis is more likely (Dumbleton et al., 2002). Furthermore, the normal repair 
mechanisms that are responsible for preventing the formation of osteolytic lesions are 
unable to halt the disease progression (Kadoya et al., 1998). Therefore, an 
individual’s biological response to the presence of wear debris may play an important 
role in the development of osteolysis. This may explain why in some cases osteolysis 
is not progressive, whilst in others the biological process is more aggressive and 
eventually results in loosening (Harris, 2001).
1.21 Wear and Osteolysis
Linear wear rate is most often used in studies to measure the presence and 
development of osteolysis rather than volumetric wear. Linear wear rate is defined as 
the penetration of the metallic head into the plastic cup liner and is measured on a 
series of radiographs. A hip bearing wear rate of 0.1mm / year has been suggested as 
the wear threshold for polyethylene (Dumbleton et al., 2002). The incidence of
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osteolysis rises significantly as the linear wear rate rises above 0.1 mm/year, whilst 
lesions are rare at a wear rate o f less than this level (Chamley and Hailey, 1975).
1.3 Classification of Osteolytic Defects
The defects that result from osteolysis can be classified according to the AAOS 
system as being cavitary or segmental (Table 1.1, Fig 1.3). Cavitary defects do not 
compromise the mechanical integrity of the involved skeleton, whereas segmental 
defects severely compromise mechanical integrity (D'Antonio et al., 1993). Another 
classification system is based on the location and extent o f femoral bone loss (Table 
1.2), with the adequacy of the metaphyseal, diaphyseal and cancellous bone in the 
femur used to predict reconstructive options (Paprosky and Burnett, 2002). For the 
acetabulum (Table 1.3), a radiographic classification system is based on the antero­
posterior (A?) pelvis plain film that predictably classifies the defect found at the time 
of surgery and allows for preplanning (Paprosky and Burnett, 2002).
1.4 Clinical and Radiographic Manifestations of Osteolysis
Radiolucent lines are seen around the loose prosthesis on radiographs, most 
commonly in the lateral and anterior aspects of the femur (Masri et al., 1998) (Fig 
1.4). Radioisotope scans may reveal areas of increased activity in areas of loosening. 
Radiographic manifestations o f periprosthetic osteolysis around total hip 
replacements can be classified into two main groups, i.e. expansive and linear (Masri 
et al., 1998) (Fig 1.5). In linear wear, the radiolucent lines form and expand around 
the periphery of the prosthesis. Successively, the lines which correspond to 
the osteolytic process become thicker. The loose tissues, together with the cells that 
are responsible for the removal of bone, expand successively around the whole
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surface of the total hip components. Eventually all surfaces o f the prosthesis are in 
contact with soft connective tissue only and all fixation between the prosthesis and 
the skeleton is lost, rendering the prosthesis loose. In expansile wear, the osteolytic 
process starts on a small area and spreads into the skeleton, away from the surface of 
the prosthesis (Zicat et al., 1995). The skeleton may bulge outward under pressure, 
thus the name "expansile".
In the majority o f cases, radiographic evidence of the disease process only manifests 
five years or more after the insertion of the prosthesis (Harris, 2001). Clinically, most 
patients are asymptomatic and diagnosed only following an incidental finding on late 
post-operative radiographs (Harris, 2001). In a minority of cases, patients are 
symptomatic and present with thigh pain (usually indicating femoral component 
loosening), groin pain (usually indicating acetabular loosening) or fractures of the 
femur or acetabulum.
Category Description
I Segmental deficiencies
• Proximal
Partial (anterior, medial or posterior) 
Complete
• Intercalary
• Greater Trochanteric
II Cavitary deficiencies (Cancellous, Cortical, Ectasia)
III Combined Segmental and Cavitary
IV Malalignment (Rotational or Angular)
V Femoral Stenosis
VI Femoral Discontinuity
Table 1.1: AAOS Femoral Bone Loss Classification System
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Figure 1.3: AAOS Classification system of femoral bone loss: (I) Segmental, (II) 
Cavitary (III) Combined (taken from D’Antonio et al., 1993).
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Linear OsteolysisStable Prosthesis 
Figure 1.5: Schematic representation of expansile and linear
Expansile Osteolysis
Figure 1.6: Endo-Klinik classification of femoral bone loss (taken from Gozzard et 
al. 2003).
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Table 1.2: Paprosky Classification System of Femoral Bone Loss (taken from 
Paprosky & Burnett, 2002).
33
Table 1.3 Paprosky Classification of acetabular defects (taken from Paprosky & Burnett, 2002)
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Figure 1.4: Radiographic appearance of osteolysis, (a) Proximal femur, (b) 
acetabulum and (c) plain film and 3D segmented CT of periacetabular osteolysis. 
Regions of osteolysis are indicated by arrows. The virtual reconstruction shows, 
separately, the femoral and acetabular components o f the prosthesis and the pelvic 
bones. The reconstruction of the region of periprosthetic osteolysis is shown between 
these two structures in red (taken from arthritis.com).
35
CHAPTER 1
1.5 Management of osteolysis 
1.5a Prevention
The first step in the management of osteolysis is to minimise its occurrence. This can 
be achieved in several ways. Firstly, design features including modularity, geometry 
and implant fixation have been shown to be among the most important variables 
relating to the generation of wear particles (Callaghan, 1995). Therefore, with 
advances in modem technology and improvements in implant design it is hoped that 
the prevalence of wear and more importantly osteolysis can be minimised. The 
femoral head size has been shown to be an important factor affecting wear. With 
metal on polyethylene articulations, increased head size is associated with increased 
volumetric wear and a higher cumulative revision rate (Livermore et al., 1990; Eggli 
et al., 2002). The dimension of the femoral head should be selected to assure a 
minimum of 6mm and ideally 8mm in polyethylene thickness (Bartel et al., 1986). As 
for the material, titanium femoral heads should be avoided because they have been 
shown to wear excessively compared with cobalt chrome, stainless steel or ceramic 
heads (Agins et al., 1988).
Secondly, it is important to prevent wear debris from gaining access to the bone- 
implant interface. In cemented femoral components, the path of least resistance for 
particle migration is along the cement-implant or the cement-bone interface. During 
normal gait high intra-articular pressures are generated which drives joint fluid and 
particles towards the cement-bone interface. Any defects or fractures within the 
cement mantle or debonding at the cement-implant interface will allow the ingression 
of particulate debris with subsequent osteolysis. The use an efficient cementing 
technique can diminish the effective joint space and seal the entrance to the femoral
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component. This is reflected in the low incidence of osteolysis, at long-term follow- 
up, with the use of cemented femoral stems inserted using second-and third- 
generation cementing techniques (Goetz et al., 1994; Mulroy and Harris, 1997). In 
cementless systems, prostheses that do not have a circumferential porous surface 
may allow the formation of fibrous channels through which particulate debris may 
enter (Coathup et al., 2001; Freels et al., 2002). In patch-porous coated implants, the 
path of least resistance is often along the smooth portion of the stem into the femoral 
diaphysis (Schmalzried et al., 1992). This is evident in a high incidence of femoral 
diaphyseal osteolysis noted in many clinical series using patch porous-coated 
components (Maloney and Woolson, 1996; Hallan et al., 2006). The use of 
circumferential porous coating aims at creating a seal at the proximal femur since a 
bioactive surface with osseointegration has an efficient sealing effect (Schmalzried 
and Harris, 1992). Circumferential porous-coated stems have usually shown low rates 
of femoral osteolysis at long term follow-up (Bojescul et al., 2003; Xenos et al., 
1999; Archibeck et al., 2001).
Thirdly, new bearings for total hip arthroplasty have been introduced with the aim of 
reducing the number of biologically active wear particles. There are two approaches; 
one is to improve the wear resistance of polyethylene through cross linking and the 
other is to avoid polyethylene and utilise alternative bearings.
(i) Cross Linked Polyethylene
Through manufacturing processes, the polyethylene is altered to generate cross-links 
between the polymer strands, generating a more wear-resistant material. In recent 
years, there has been a rapid expansion in the use of highly cross-linked polyethylene
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in the USA and Europe with some countries using it in nearly two thirds of all their 
hip replacements (Kurtz SM, 2004). Laboratory wear testing of highly cross-linked 
polyethylenes in hip joint simulators have shown a significant resistance to wear with 
some studies reporting over 90% reduction in wear even under adverse conditions, 
such as with large-diameter femoral heads, with roughened femoral heads, and in the 
presence of third-body particles (Affatato et al., 2005; McKellop et al., 1999; 
Muratoglu et al., 2001; Kurtz et al., 1999; Harris, 2004). These findings have been 
confirmed by retrieval studies of first generation highly cross-linked polyethylene 
acetabular components (Oonishi and Kadoya, 2000; Oonishi et al., 2001) and 
randomised controlled trials comparing second generation highly cross-linked 
polyethylene with standard UHMWPE (Glyn-Jones et al., 2008).
When evaluating the clinical published reports on the use of highly cross-linked 
polyethylene, two important factors must be taken into account. Firstly, although the 
wear rate of the highly cross-linked polyethylene during the early years of clinical use 
have been shown to be lower than that o f traditional polyethylenes, the amount of 
reduction has been lower than that predicted with hip-simulator wear testing (Jacobs 
et al., 2007). This difference is most likely due to the fact that there is a biphasic 
pattern of penetration of the ball into the cup; the initial phase is rapid and creep- 
dominated and the latter phase is slower and dominated by wear (Digas et al., 2004). 
Therefore, a significant problem with the assessment of polyethylene wear in vivo is 
the determination of when creep-dominated penetration slows and when wear- 
dominated penetration begins (Jacobs et al., 2007). Secondly, when the amount of 
reduction in wear is compared among clinical studies of different highly cross-linked 
polyethylenes, the type of polyethylene used for the control group must be taken into
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account. This is due to the fact that traditional polyethylene cups that are sterilised 
using gamma irradiation ranging from 2.5 to 4 Mrad (25 to 40 kGy) have a certain 
amount of cross-linking that, on the basis o f hip-simulator studies, would result in 
wear rates that are about 50-75% lower than those of non-cross-linked polyethylene 
cups (McKellop et al., 1999).
Some studies have raised concerns about the mechanical properties of highly cross- 
linked polyethylene which has decreased toughness and elastic modulus when 
compared with standard UHMWPE (Baker et al., 1999; Baker et al., 2003). Another 
study has reported wear and surface fatigue cracking, as early as ten months after 
implantation of a highly cross-linked ultra-high molecular weight polyethylene 
acetabular liner (Bradford et al., 2004). In addition, hip-simulator results of wear 
resistance can differ greatly from those of clinical studies (Graeter and Nevins, 1998; 
Glyn-Jones et al., 2008) and for this reason some authors advocate that clinical trials 
are essential before highly cross-linked polyethylene becomes so widely used (Glyn- 
Jones et al., 2008). Furthermore, cross linked polyethylene has been shown to release 
a relatively large number of wear particles that are more biologically active than that 
produced by non cross-linked polyethylene (Endo et al., 2001). Therefore, the amount 
o f cross-linking that leads to the least amount of wear debris production is yet to be 
determined. Although short to mid term studies for cross-linked UHMWPE seem 
encouraging, longer follow ups are required.
(ii) Ceramic on ceramic
First generation ceramic-on-ceramic bearings were complicated by neck-socket 
impingement, ceramic fractures, isolated accelerated wear from chipping, and implant
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loosening (Campbell et al., 2004). Both impingement and implant loosening were 
largely design problems and unrelated to the bearing surface (Holmer and Nielsen, 
1993). The incidence of ceramic fracture during this period was primarily due to 
manufacturing flaws, lack of testing standards and poor tolerances for taper designs 
(Campbell et al., 2004). More recent processing techniques may have eliminated 
these problems. Newer generation of ceramic components including alumina and 
zirconia ceramic have a low coefficient of friction and superior wear characteristics 
compared with metal (Campbell et al., 2004).
Ceramic on ceramic articulations are estimated to have 150-300 times less linear wear 
and 1700 times less volumetric wear than conventional metal-on-polyethylene 
articulations (Campbell et al., 2004). Although, in vitro studies have shown that 
ceramic wear debris is not biologically active (Sterner et al., 2004), there is clinical 
evidence to demonstrate that it can cause osteolysis (Yoon et al., 1998). Early results 
with the use of ceramic-on-ceramic hip replacements have shown encouraging results 
with low osteolysis rates (Murphy et al., 2006; Colwell, Jr. et al., 2007). However, 
further studies will be needed to show that the wear resistance demonstrated by 
ceramics in vitro and early clinical studies actually reduces osteolysis in the long 
term.
(iii) Ceramic on UHMWPE
The penetration rate of ceramic on polyethylene bearing is between 25-50% of that 
observed in metal on polymer articulations (Wroblewski et al., 1999). Clinical studies 
have shown impressive long term results with the use of ceramic-on-polyethylene 
bearing surfaces (Urban et al., 2001). Although wear rates with ceramic on
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polyethylene are lower than that reported with metal-on-polyethylene. This 
reduction is small compared with hard-on hard bearings and metal on highly cross- 
linked UHMWPE (Campbell et al., 2004). Furthermore, the UHMWPE wear debris 
and its associated problems are still present which may explain why ceramic-on- 
UHMWPE bearing has not consistently shown lower rates o f osteolysis (Campbell et 
al., 2004). In clinical practice, the use of ceramic is limited by expense and a small 
risk (<0.01%) of head fracture (Fritsch and Gleitz, 1996).
(iv) Metal on metal
Metal-on-metal bearings were employed early in the development of THRs and were 
commonly used until the mid-1970s but were abandoned largely because of high 
revision rates (Amstutz et al., 1996) and the success of the metal on UHMWPE 
Chamley prostheses. Early designs were complicated by high frictional torque from 
inadequate head-cup clearances, which limited lubrication and contributed to 
subsequent implant loosening (Campbell et al., 2004). Despite this, in 1990, 
Jacobsson reported the 20-year survival rate of metal-on-metal McKee-Farrar THR to 
be 77%, which was comparable to the 73% 20-year survival rate of the Chamley hip 
(Jacobsson et al., 1990). In addition, fewer osteolytic lesions occurred in patients with 
metal-on-metal THRs than in those with Chamley THRs (Jacobsson et al., 1990).
Recently, metal-on-metal bearings have been reintroduced with improved materials, 
design, manufacturing and modularity. Metal-on-metal articulations have several 
attractions that have resulted in a resurgence o f their use. These include improved 
wear resistance and the ability to self-heal, i.e. to polish out isolated surface scratches 
caused by third body particles. Furthermore, although metal-on-metal bearings 
produce more wear particles than UHMWPE (Sieber et al., 1999), the metallic wear
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debris is smaller (50-500nm) in comparison with those that activate macrophages 
(0.5-1pm) and so do not evoke an inflammatory response. This is reflected in some 
clinical reports demonstrating absence of osteolysis with metal-on-metal articulations 
at a 9 year follow-up (Dorr et al., 2000). However, other authors have reported a 
femoral osteolysis prevalence of between 2.6-5.5% in patients treated with second 
generation metal-on-metal hip arthroplasties (Carr and DeSteiger, 2008; Park et al., 
2005).
There has been some resistance to using metal articulations because of the evidence 
that systemic metal levels are higher in patients with these components (Hallab et al.,
2000). This is concerning for two main reasons. Firstly, metal hypersensitivity is 
suspected to be responsible for some cases o f osteolysis and subsequent implant 
failure (Park et al., 2005; Hallab et al., 2000). Secondly, there is concern that 
persistently elevated metal levels raises the theoretical risk of toxicity and 
carcinogenicity (Jacobs et al., 1998). Although some authors have showed no 
significant increased risk of malignancies following metal-on-metal articulations 
(Visuri et al., 2006), longer term follow-up especially in younger patients is required.
1.5b Treatment of femoral osteolysis
Despite changes in device designs, implants, materials and fixation methods, revision 
rates remain at around 10% after 10 years, with cemented prostheses having a lower 
revision rate than uncemented prostheses (NICE, 2000). Most patients with aseptic 
loosening will, therefore, need to undergo revision surgery. Currently, revision hip 
replacements account for around 15-18% of total hip arthroplasties in the UK and 
USA (National Audit Office, 2003; Dixon et al., 2004; Kurtz et al., 2005). 
Furthermore, at a time when the average life expectancy is continuing to rise, joint
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replacements are being performed on ever-younger patients (Dixon et al., 2004). It 
can therefore be expected that the need for revision hip arthroplasty will continue to 
rise for the foreseeable future. Indeed, studies have shown that the number of revision 
THRs will increase by over 137% over the next twenty-five years (Kurtz et al., 2005).
The two main aims of a revision procedure are to achieve immediate fixation and 
long- term stability. However, the reduction of bone stock available for subsequent 
implant fixation probably accounts for the inferior results attained in revision surgery 
compared with the primary procedure (Pellicci et al., 1985; Sporer and Paprosky, 
2004; Krishnamurthy et al., 1997). This is partly due to the inadequate amount and 
poor quality of bone available into which the new prosthetic components can be fixed 
and partly due to the fact that the existing bone is often not strong enough to support 
the loads that are placed on the prosthetic components (Amstutz et al., 1982; Salvati 
et al., 1975; Stauffer, 1982). Furthermore, the bone loss that accompanies aseptic 
loosening is often extensive and involves many areas in combination (Behairy and 
Jasty, 1999). In an attempt to overcome this problem, several considerations must be 
taken into account when managing the patient with osteolysis.
In the asymptomatic patient, factors such as patient age, past medical history, degree 
and type of bone loss, rate o f progression of osteolysis, properties o f the implant to be 
revised, and patient’s activity level must be borne in mind. Surgery is usually 
indicated if bone loss is extensive or progressive (Stauffer, 1982). Curettage and 
grafting of the defects, stem retention with exchange of the femoral head is a viable 
option in the asymptomatic patient with a well-fixed stem (Berry, 2003). In the 
medically unfit patient or in the elderly, a non-surgical approach with regular follow- 
up is a reasonable.
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In the symptomatic patient, surgery is usually warranted and is guided by host factors 
mentioned above and the extent of femoral bone loss. The main principles in the 
management of osteolysis are to identify and remove the source of the wear particles, 
remove the loose components and fill in any defects. In Paprosky Type I defects 
(Della Valle and Paprosky, 2004) there is minimal damage to the proximal 
metaphysis and the case can be approached like a primary femoral hip arthroplasty 
using any primary cemented or uncemented stem (Dunbar et al., 2001). However, 
even in these cases less than optimal results have been reported with the use of 
cemented and proximally coated primary hip stems (Sierra and Cabanela, 2002).
In type II defects, there is meta-diaphyseal bone damage with an intact diaphysis 
whilst in type IIIA defects, the metaphysis is damaged severely; a minimum of 4cm 
of intact cortical bone is present in the femoral isthmus (Della Valle and Paprosky, 
2004). In these cases, the early results of cemented revision of the femoral component 
were disappointing (Callaghan et al., 1985; Kavanagh and Fitzgerald, Jr., 1987). One 
reason for the poorer results was attributed to early cementing techniques which 
failed to obtain adequate mechanical fixation in the sclerotic, smooth intramedullary 
canals encountered after removal o f a failed prosthesis. With the introduction of 
second- and third-generation cementing techniques and longer stems to obtain cement 
fixation in the distal undamaged cancellous bone, some authors have shown 
encouraging results (Mulroy et al., 1995; Smith et al., 1998; Raut et al., 1995; Collis, 
1993) whilst, others have shown an unacceptable failure rate and there are no 
benefits of revision using improved cementing technique (Eisler et al., 2000). The 
best results have been observed in older patients (Mulroy et al., 1995; Hay don et al., 
2004) but in the younger patient the results have been disappointing (Stromberg and
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Herberts, 1996; Haydon et al., 2004). Furthermore, in patients who have had revision 
of failed uncemented femoral components with use of cement, the rate of loosening at 
mid-term follow-up is even higher than that reported after revision of failed cemented 
implants with the use of cement (Davis, III et al., 2003).
If a cemented component is used, it should pass the most distal cortical defect by at 
least two to three cortical diameters in order to minimise strain and creation of stress 
raisers on the femur (Panjabi et al., 1985). This often involves the use of a long stem 
prosthesis that extends beyond the isthmus of the femur. However, in this region the 
effectiveness o f the cement-restrictor is reduced and therefore effective cement 
pressurisation is not achieved (Dunbar et al., 2001). Furthermore, in the presence of a 
femoral cortical defect, cement can extrude into the soft tissues making it difficult to 
obtain adequate cement pressurisation. This may further explain why the incidence of 
loosening and re-revision has been high in many series reporting the results of 
cemented revision procedures (Eisler et al., 2000; Stromberg et al., 1992). In addition, 
the bone-cement shear strength is only one-fifth o f the shear strength after primary 
hip arthroplasty (Dohmae et al., 1988). Some authors have advocated that for these 
reasons, cement should never be used for revision surgery (Wirtz and Niethard,
1997). In modem times, cemented revision of the femoral component has been 
reserved for the elderly or the patient with reduced mobility but not for the younger 
patient in whom there is a realistic probability of further revision surgery.
Due to the high rate of mechanical failure observed with cemented revision, many 
surgeons now use cementless implants (Sporer and Paprosky, 2003). Bone ingrowth 
into a cementless prosthesis can be achieved using both porous and hydroxyapatite 
coatings (Bolognesi et al., 2004). Both designs depend on obtaining an initial stability
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and subsequent bone ingrowth. The ability to achieve bone ingrowth correlates with 
the degree of preoperative proximal bone deficiency and the extent to which the 
femoral canal is filled with prosthesis (Hedley et al., 1988; Harris et al., 1988; 
Moreland and Bernstein, 1995; Moreland and Moreno, 2001). As the metaphysis is 
somewhat supportive in type II defects, a proximally-coated, non-cemented implant 
with diaphyseal stabilisation can be used or distal fixation can be achieved with an 
extensively porous-coated implant. However, in type IIIA defects, metaphyseal bone 
is often deficient and sclerotic or avascular and for this reason the results of revision 
with proximally porous-coated stems have been disappointing (Berry, 2003; Mulliken 
et al., 1996). An extensively-coated implant is most commonly used for type III 
defects and is designed to bypass the regions of proximally deficient bone and obtain 
stability and fixation in more distal femoral bone. Many studies have shown 
promising mid- and long-term results with the use of uncemented extensively-coated 
prosthesis for femoral component revision in these defects (Moreland and Bernstein, 
1995; Moreland and Moreno, 2001; Paprosky et al., 1999; Weeden and Paprosky, 
2002; Ng et al., 2004). One study has shown that reliable femoral fixation can be 
achieved in up to 95% of patients with type II or type IIIA femoral defects (Sporer 
and Paprosky, 2003). However, several concerns have been raised about the use of 
extensively porous-coated cobalt stems. These include: thigh pain, stem fracture, 
periprosthetic fracture, late component loosening and proximal stress shielding 
(Moreland and Bernstein, 1995; Moreland and Moreno, 2001). Stress shielding may 
be reduced with the use of hydroxyapatite-coated stems (Capello et al., 1998; 
Malhotra et al., 2008).
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A Type IIIB defect is characterized by a severely damaged metaphysis with less than 
4cm of cortical bone present distal to the isthmus (Sporer and Paprosky, 2003). In a 
Type IV defect there is extensive meta-diaphyseal damage and the femoral canal is 
widened; the isthmus is non-supportive and distal fixation is difficult to achieve 
(Sporer and Paprosky, 2003). In type IIIB defects, a fully porous-coated stem can be 
used successfully if  the femoral canal is less than 19mm (Sporer and Paprosky, 2003). 
In canals wider than 19mm and in type IV defects, the use o f extensively-coated 
implants has a much higher mechanical failure rate than that seen with lesser defects 
(Weeden and Paprosky, 2002; Sporer and Paprosky, 2003; Della Valle and Paprosky, 
2004). Furthermore, a bowed stem will follow the natural anterior bow of the femur 
and will not allow independent positioning of the component. As a result, a femur 
that has a torsional deformity with a femur that has remodelled in retroversion will be 
at risk for posterior dislocation (Sporer and Paprosky, 2003).
One alternative to attain axial and rotational stability within a deformed femur is to 
obtain distal fixation with the use of a fluted tapered stem (Hartwig et al., 1996). This 
technique originally was popularized in Europe with the use o f the Wagner implant 
(Sulzer Medica, Winterthur, Switzerland). The original design was a monoblock 
fluted titanium tapered stem designed to provide axial stability through a wedge fit 
caused by the taper while the flutes allow for rotational stability. The results o f this 
type of implant have been acceptable and in some series have shown reconstitution of 
bone stock (Isacson et al., 2000; Kolstad et al., 1996; Bohm and Bischel, 2001; Bohm 
and Bischel, 2004). However, known complications include stem subsidence, 
dislocation and discrepancies with leg length (Bohm and Bischel, 2004). 
Furthermore, because metaphyseal and diaphyseal bone loss can be highly variable, it
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can often be difficult to position the femoral head centre at the correct length, neck 
offset, and ante version with the one-piece stem of this type.
The advent of modular femoral components with multiple-sized proximal and distal 
stems have evolved to achieve maximal fit o f the distal tapered against the isthmus 
and proximal support to preserve any remaining metaphyseal bone. Modular implants 
essentially offer distal fixation with proximal stability (e.g. Restoration Modular, 
Stryker, Mahwah, NJ) or proximal fixation with distal stability (e.g. S-ROM, DePuy 
Orthopaedics, Warsaw, Ind) (Haddad et al., 2007). These options help establish a 
stable hip centre and correctly tension soft-tissue to prevent dislocation. The 
intermediate-term results with this type of implant have been encouraging (Bono et 
al., 2000; Wirtz et al., 2000; Kwong et al., 2003; Christie et al., 2000; Cameron, 
2002). However, the long-term results of this type o f implant are lacking and it 
remains to be seen whether modularity ultimately improves survival rates in revision 
hip surgery.
In the most severely deficient proximal femur, another treatment option includes the 
use of an allograft-prosthesis composite whereby a long-stem prosthesis is cemented 
to a proximal femoral allograft but not to the host bone. One study (Blackley et al.,
2001) has shown promising clinical and radiographic results at an average of eleven 
years after revision hip arthroplasty with this technique. However, this technique is 
technically demanding and expensive. In addition, although the allograft may heal to 
the remaining host bone, there is concern that with time resorption may occur 
rendering the composite unstable (Della Valle and Paprosky, 2004). In the elderly or
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low-demand patient, a final reconstructive option includes proximal femoral 
replacement using a, modular bone tumour type of prosthesis.
Despite the many reconstructive options during revision o f the femoral component, 
there are no studies that have directly compared the results of different femoral 
revision techniques in a prospective randomised fashion. Unfortunately, these types 
of studies require large numbers of patients and long periods o f follow-up making 
them difficult to accomplish. Furthermore, it is oftentimes difficult to compare the 
results of reports because the severity o f preoperative bone loss seen at the time of 
revision THR is variable, and many reports do not use a classification system to allow 
a comparison o f the results of different reconstructive techniques when applied to 
similar clinical situations.
1.5c Acetabular Revision Options
The goals of acetabular revision surgery are to restore the biomechanics of the hip 
and to restore structural integrity and continuity. The results o f cemented acetabular 
revisions have been disappointing (Amstutz et al., 1982). Cemented reconstruction 
using allograft has also produced discouraging results (Jasty et al., 1990). 
Uncemented porous-coated sockets can be used successfully to reconstruct most 
acetabular defects encountered during revision surgery (Dorr and Wan, 1995). 
Screws or cages may need to be used to secure the acetabular component into the 
pelvis. Where major segmental defects are present and prosthetic stability is not 
possible in host bone, structural allografts are often used.
[lOHDoif]
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1.6 Bone grafts and revision surgery
Bone grafts have increasingly been used to replenish the bone loss that occurs with 
loosening (Gross and Goodman, 2004; Emerson, Jr. et al., 1989; Head et al., 1999). 
Bone has three unique properties that are essential for successful healing and 
incorporation of bone grafts (Garbuz et al., 1998). These include osteogenesis (ability 
of bone to self-generate new bone formation), osteoinduction (ability to recruit 
mesenchymal stem cells, from the surrounding host, which then differentiate into new 
bone) and osteoconduction (process of ingrowth of capillaries, perivascular tissue and 
osteoprogenitor cells from the host bed into the graft structure) where the graft 
functions as a scaffold for the ingrowth of new bone.
1.6a Autografts
Autografts are considered the gold standard of bone transplantation because they 
possess all three unique properties described above (Garbuz et al., 1998). They are 
usually obtained from the iliac crest, femoral head or the fibula of the patient. There 
are, however, several limitations with the use of autografts: (1) only a restricted 
amount of bone can be acquired by this technique and this is usually insufficient to 
fill the large defects that are associated with loosening. (2) Harvesting the graft from 
the patient’s own skeleton can compromise the normal skeletal architecture and the 
mechanical integrity of the donor site. (3) Donor site complications and morbidity can 
result in increased patient recovery time, disability and chronic pain (Vaccaro, 2002). 
(4) The acquisition of bone graft increases operative time and blood loss. (5) Viable 
cells harvested from the donor site may not survive when they are detached from their 
vascular supply (Vaccaro, 2002).
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1.6b Allografts
Due to the above mentioned problems with autografts, allografts bave become an 
attractive alternative. These are most often obtained from the femoral beads of other 
patients undergoing THR’s, or from the femurs or tibias harvested from fresh 
cadavers. Although the use of allografts in the form of morsellised chips to fill 
cavitary defects has had good clinical success (Berry and Muller, 1992; Padgett et al., 
1993) their use in revision surgery has shown inconsistent results (Hozack et al., 
1996). Unlike autografts, they only possess osteoconductive and limited 
osteoinductive properties and remodel at a much slower rate (Vaccaro, 2002). This 
restricted capacity to remodel may be the cause of fractures observed in large weight- 
hearing allografts and also has substantial practical significance in terms of the 
method of fixation of allograft to the host bone (Berrey, Jr. et al., 1990).
There are also several other disadvantages of using allografts. For example, up to a 
fifth of all donated femoral heads have been shown to be contaminated with bacteria 
(Sommerville et al., 2000). Furthermore, grafts have been known to transmit 
pathogens to the patient such as hepatitis B, hepatitis C, HIV and may contain prions 
(Tomford, 1995; Betz, 2002). In addition, bone allografts have been shown to be 
immunogenic (Bos et al., 1983). In contrast to autografts, allografts in general have a 
higher incidence of delayed incorporation, non-unions, delayed unions and failure 
rates (Gross et al., 1995; Bos et a l, 1983; Behairy and Jasty, 1999). Allografts are 
also not viable at the time of implantation and serve only as a passive scaffold for 
subsequent revascularisation and osseous ingrowth.
Finally, due to the increased use of allografts, demands for cancellous allografts may 
outstrip supply in the future (Galea et al., 1998). Grafts can be used as particulate
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grafts to fill cavitary defects or as bulk structural grafts to support the prosthetic 
components. Concerns with the use of bulk allografting include that graft union to the 
host bone can be significantly delayed (Gross et al., 1995) and that they do not 
actually replenish host bone stock because they remain unviable (Duncan et al.,
1998). Structural grafts have to be stabilised to the existing host bone and early 
revascularisation can compromise the rebuilding process and cause structural 
inadequacy (Behairy and Jasty, 1999).
1.6c Allograft preparation and storage
Tissue banks use a variety of techniques in bone allograft acquisition and preparation. 
With the increased risk o f disease transmission, gamma irradiation or ethylene oxide 
are commonly used to sterilise the allografts. However, there are disadvantages with 
both methods. For instance, gamma radiation can adversely affect the mechanical and 
biological properties o f bone allografts by degrading the collagen in bone matrix 
(Nguyen et al., 2007). Although ethylene oxide does not affect the mechanical 
properties of the graft (Davy, 1999), it can impair the bone conductive properties of 
fresh frozen bone grafts (Aspenberg and Lindqvist, 1998). Furthermore, the residual 
debris remaining after ethylene oxide treatment can evoke an inflammatory response 
and for this reason this sterilisation method is not commonly used for musculoskeletal 
grafts (Stevenson, 1999). Following sterilsation, allografts need to be stored prior to 
transportation to a medical facility. Commonly, the bone allografts are either frozen 
or freeze dried. The advantage of freezing the graft is that it reduces the immunologic 
response without greatly affecting the mechanical properties (Boyce et al., 1999). 
However, the problem with fresh frozen bone allografts is that they must be 
continuously stored at low temperatures, including when transported, and they need
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to be thawed prior to use. Freeze drying the graft reduces the moisture content to less 
than 6%, thus allowing storage for up to five years at room temperature (Ibrahim et 
al., 2004). The disadvantage of freeze drying is that the allograft will need to be re­
hydrated prior to use and rehydrating the bone is reported to restore only about 90% 
of its original properties. This restoration is dependent on physician compliance with 
the rehydration process (Boyce et al., 1999). The freeze-drying process may also 
reduce the compressive strength and rigidity of the allograft (Boyce et al., 1999). 
Furthermore, it has been reported that the incorporation of freeze-dried grafts can be 
delayed, with revascularisation and callus formation being reduced compared with 
other forms of allograft (Stevenson et al., 1997).
1.7 Impaction grafting
Another method that has been employed to treat cavitary defects, in the proximal 
femur, is the use of impaction grafting, whereby morsellised cancellous allograft is 
impacted into the proximal femur and the revision prosthesis usually cemented into 
the canal (Fig 1.7). Whilst in structural grafts, bone ingrowth does not usually exceed 
2 to 3mm (Enneking and Mindell, 1991; Hooten, Jr. et al., 1996), in impacted 
morsellised allografts the bone growth distance has been shown to be greater (Ling et 
al., 1993). Furthermore, this is the only technique, to date, that has been shown to 
reverse the loss of bone stock caused by osteolysis (Morgan et al., 2004; Morgan et 
al., 2004).
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1.7a History of Femoral Impaction Allografting
Impaction grafting using either autograft or allograft was initially introduced on the 
acetabular side in the treatment of protrusio acetabuli (Hastings and Parker, 1975; 
McCollum et al., 1980). It was subsequently used in the treatment of acetabular 
osteolysis during revision hip (Slooff et al., 1984; Schreurs et al., 1998). The first 
clinical reports of impaction allografting on the femoral side were in relation to 
revision with cementless stems (Nelson et al., 1990). Although the cementless 
method continues to attract some attention (Keblish et al., 1996), the use of 
morsellised bone with cement has attracted more enthusiasm over the last decade. 
This was first described by the Exeter group (Gie et al., 1993) and later by another 
group (Elting et al., 1995).
awed
head
bone 
cement
impacted
bone
chips
Figure 1.7: Impaction bone grafting of the femur. Allograft is morsellised from 
donor femoral heads and placed in areas of defect. This is impacted and revision 
prosthesis cemented in place.
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1.7b Technique of Impaction Allografting
The technique of impaction allografting, as described by the originators, has evolved 
since that reported in the original series from Exeter (Gie et al., 1993). Most 
techniques now try to maximise the impaction of the allograft, minimise the potential 
for intraoperative or postoperative fractures, and permit the use of femoral implants 
with variable stem lengths, neck lengths, and neck offsets (Stulberg, 2002). On the 
femoral side, the surgery involves removing the old prosthesis, cement and fibrous 
membrane. Where necessary this is followed by placing cerclage wires or stainless 
steel mesh around the proximal femur and on lay struts over the proximal cortical 
defects. The femoral canal is blocked using a special revision polyethylene plug 
positioned at least 20 mm distal from the anticipated position of the stem tip and a 4 
mm diameter guide wire is screwed into the revision plug, which ensures central 
compaction of the graft. A series of increasing diameter bulbous rods (distal 
impactors) (Fig 1.8) that slide over the guide wire, are used to impact the graft 
distally. To create space for the new stem, a proximal impactor (Fig 1.8) is driven into 
the graft. The former is of similar shape but marginally larger then the stem, to allow 
for a cement mantle. All distal and proximal impactors attach to a special slap 
hammer (Figs 1.8 & 1.9) to aid the impaction process. During proximal impaction, 
graft is added in stages and it is advised that the proximal impactor should be driven 
into the graft until it is “so tight that it is impossible to withdraw it without using the 
slap hammer”. Once the femur is fully impacted, more chips can be impacted using 
small hand taps around the top of the stem shaped impactor.
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Figure 1.8: Exeter X-change femoral impaction grafting instruments: proximal 
impactors (A), distal impactors (B) and slap hammer (C).
For revision acetabular reconstruction, the old implant, cement and fibrous interface 
are removed. Where necessary defects are closed using wire meshes, which are 
screwed into place (Figl.lO). The bone chips are packed into the small cavities, and 
then layer by layer the entire socket is filled with the graft using different sized, hand 
held, domed impactors that can be struck with a hammer (Fig 1.9). The last impactor 
should be 2 -  4 mm larger than the cup diameter to accommodate the cement used for 
fixing the cup into position. At least two femoral heads are recommended for 
acetabular or femoral reconstruction.
1.7c Allograft preparation in impaction allografting
Impaction grafting is most commonly performed using fresh frozen femoral head 
allograft which is thawed at the time of surgery and milled to the required size. On
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the femoral side, the use of a bone mill to produce 2-4mm chips is suggested, 
however, larger particles, of approximately 10 mm are recommended for the 
acetabulum (Toms et al., 2004). The most commonly used alternative to frozen 
allograft is processed bone (freeze dried or irradiated bone). Rarely, xenografts and 
autografts are utilised but as they are so infrequently used that they will not be 
discussed further. The surgical technique is the same regardless of the type of graft 
used.
The use of fresh frozen allograft has been associated with the best long term results 
(Schreurs et al., 2005). However, the major disadvantage with its use is the possibility 
of transmission of pathogens to the patient such as hepatitis B, hepatitis C or HIV 
(Tomford, 1995; Betz, 2002; Simonds, 1993; Conrad et al., 1995). Although 
processed bone has less potential for disease transmission, there have been concerns 
that it may have inferior mechanical properties compared with fresh frozen bone 
(Pelker et al., 1984; Tokgozoglu AM et al., 2000). However, recently in vitro studies 
have shown freeze-dried graft may provide a more stable fixation of the stem than 
fresh-frozen morsellised graft (Cornu et al., 2003). Furthermore, the compaction of 
freeze-dried bone is faster than that of fresh-frozen bone with freeze-dried grafts 
requiring three to four times fewer impactions to achieve the same stiffness (Cornu et 
al., 2003). As it is easier to impact freeze-dried bone it may be mechanically more 
efficient than the fresh-frozen bone in surgical conditions (Cornu et al., 2003). 
Clinical studies using processed bone have shown inconsistent results (Thien et al., 
2001; Buckley et al., 2005; de Roeck and Drabu, 2001; Robinson et al., 2002; 
Tokgozoglu et al., 2000) and it is not clear if the type of bone graft used or minor 
variations in technique are responsible for the differences in outcome. However, one
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study has shown that the addition of autologous bone marrow to irradiated bone 
significantly enhances graft incorporation with results comparable to non-irradiated 
bone (Deakiin & Bannister 2007). Currently, a review to compare the clinical 
effectiveness of processed bone against fresh frozen bone is being conducted (Board 
TN et al., 2007).
1.7d Clinical results of impaction allografting for femoral component revision
As with many developments in surgery, the clinical use of impaction allografting has 
preceded the basic scientific and biological understanding. However, over the last 
decade, the science behind impaction grafting is slowly being unravelled. When 
evaluating the published reports on impaction allografting, three important factors 
limit comparisons among clinical series. Firstly, there is major inconsistency 
regarding the criteria for inclusion within a study. In some series, only cases with 
severe advanced bone loss have been included (Masterson et al., 1997; Meding et al., 
1997; Leopold et al., 1999), whilst in other studies cases with such severe bone 
deficiencies have specifically been excluded (Gie et al., 1993; Ling, 1997). In some 
studies, inclusion criteria have not been defined at all (Eldridge et al., 1997). 
Secondly, there are a vast number of confounding variables in the published reports 
that again limit valid comparisons. For example, series have differed with respect to 
stem geometry, cement type, allograft material, surgical approach and post-operative 
care of patients (Leopold and Rosenberg, 2000; de Roeck and Drabu, 2001). Finally, 
methods of patient analysis, including clinical and radiographic assessment and 
follow-up duration, have differed markedly among published reports (Leopold and 
Rosenberg, 2000).
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Since the inception of this technique in 1985, there has been limited clinical follow- 
up on cementless femoral impaction allografting, and most follow-up series have 
evaluated the cemented method. The technique using cement has shown encouraging 
results and appears to show restoration in bone stock in a majority o f patients 
(Mikhail et al., 1999; Meding et al., 1997; Elting et al., 1995; Leopold et al., 1999; 
Gie et al., 1993).
In addition, radiological and histological graft incorporation has been reported and the 
clinical results have been promising regarding pain relief and function (Gie et al., 
1993; Emerson, Jr. et al., 1989). However, early subsidence of the femoral 
component, prosthetic dislocations and a high incidence o f intra- and post-operative 
femoral fractures have been reported (Eldridge et al., 1997; Masterson et al., 1997; 
Franzen et al., 1995). Several centres have reported short-term (minimum 18-24 
months) follow-up using cancellous impaetion grafting with cement using polished, 
tapered, collarless stems (Eldridge et al., 1997; Elting et al., 1995; Gie et al., 1993; 
Meding et al., 1997). Advocates of the technique using these devices state that 
subsidence does not automatically lead to clinical loosening because the stem’s 
wedge-shaped geometry may allow restabilisation within the cement mantle as 
subsidence occurs (Elting et al., 1995; Gie et al., 1993). Cold flow of the cement 
mantle may help the stem to subside without becoming symptomatically loose 
(Leopold and Rosenberg, 2000). Subsidence of the wedge shaped stem may also 
provide a beneficial compressive load to the bone graft (Ling et al., 1993; Nelissen et 
al., 1995), whilst some other authors have implicated subsidence as a serious 
complication and the cause of post-operative thigh pain, cement mantle fracture and 
hip dislocations (Eldridge et a l, 1997; Franzen et a l, 1995; Masterson et a l, 1997; 
Meding et al., 1997).
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Figure 1.9: Slap hammer used to aid the impaction process.
Figure 1.10: Acetabular reconstruction using impaction allografting. Defects are 
closed using wire meshes which are screwed into place. (Taken from Gie., et al 1993)
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1.7e Evidence for graft incorporation 
(i) Radiographic Analysis
The process of bone graft incorporation following impaction allografting can be said 
to be complete when the graft has been replaced by living bone forming a trabecular 
pattern with the alignment of the trabeculae associated with the transmission forces 
from the stem of the femoral component of the distal femur (Duncan et al., 1998). 
The exact pattern will depend on the design of the femoral component used.
Radiographic inference of preoperative defects and assessment of postoperative graft 
incorporation poses a major difficulty in the evaluation of this technique. 
Interpretation of post-operative radiographs is difficult in the presence of overlapping 
heterotrophic bone, wire mesh, cortical bone, cortical allograft, bone cement and the 
femoral prosthesis (Duncan et al., 1998; Gie et al., 1993).
There is no universally accepted, reliable and valid radiographic classification system 
for describing graft incorporation. The originators of the impaction technique 
proposed a radiographic grading system (Gie et al., 1993), which falls under seven 
headings: no change; localised resorption; cortical repair; trabecular remodelling; 
trabecular incorporation; cortical repair and trabecular incorporation. However, there 
are no other studies, to date, which have validated this grading system. Difficulties in 
radiographic interpretation of the changes that occur from dead bone graft to fully 
remodelled, living trabeculae are such that it is difficult to envisage a truly objective 
means of assessment. However, observed changes are strong evidence for the 
reconstitutution of living femoral bone stock with this technique (Duncan et al., 1998)
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(Fig 1.11). Where eortical and trabeeular remodelling are clearly seen, histology from 
biopsy cores have shown that this corresponds to new bone formation (Linder, 2000).
Figure 1.11: (A) Immediate post-operative radiograph following impaction grafting, 
(B) magnified image and (C) radiograph at 1 year showing thicker cortex (taken from 
Linder, 2000).
(11) Histology
Histological analysis of revised acetabuli with significant bone loss provides most of 
the indirect evidence for allograft incorporation during femoral impaction 
allografting. Progressive graft incorporation with subsequent replacement by host 
bone has been shown in a study on three revision hip arthroplasties in which 
acetabular defects were filled with impacted allograft bone chips (Heekin et al., 
1995). Other human histology studies on the revised acetabulum show 
revascularisation, new bone formation and reconstitution of the bone stock to varying
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degrees (Buma et al., 1996; Heekin et al., 1995; Lamerigts et al., 2000; van der et al.,
2002). It is important to note that incorporation of the morsellised graft is often not 
complete and frequently unpredictable (Tagil et al., 1999). In some instances 
unincorporated allograft remains, even 8 years after the procedure (Linder, 2000). 
The incorporation of the graft material depends on the ability of the host osteoblasts 
and osteoblast progenitors to invade the new scaffold and lay down osteoid, which is 
subsequently calcified.
Only a limited number of retrieval or revision series have been published to date that 
evaluate the histological results of femoral impaction allografting (Nelissen et al., 
1995; Ullmark and Linder, 1998; Ullmark and Obrant, 2002; Linder, 2000). O f these, 
only three stem designs have been the subject of histological analysis; the polished 
tapered CPT stem (Ling et al., 1993), the Lubinus stem (Ullmark et al., 2002), and 
two versions of the Chamley design (Ullmark et al., 2002; Ullmark and Linder,
1998).
In 1993, Ling et al. published a report on the histology o f a single femur retrieved 3.5 
years after a cemented revision of a hip replacement in which impaction allografting 
had been used two fill two large cortical defects. The defects were repaired with a 
combination of wire mesh and impacted allograft chips, into which a polished, 
double-tapered CPT stem was cemented. Three distinct histological zones were 
observed: an inner zone comprising mainly of dead bone trabeculae buried in cement; 
an interface zone between cement and living tissue; and an outer zone consisting 
mainly of well vascularised regenerated cortical bone with occasional islands o f dead 
bone. The authors hypothesised that the bone cement forced into the graft 
immobilises the bone trabeculae at the interface and that the regenerating bone makes
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contact with these protruding dead trabeculae. Another study evaluated the 
histological findings of a retrieved femur 6 months after a cemented cancellous 
impaction grafting using a Chamley prosthesis (Ullmark and Linder, 1998). This 
showed that most transplanted areas were revascularised and in the proximal femur 
there was new bone formation peripherally, but a substantial amount of fibrous 
stroma embedded graft pieces closer to the cement. In the diaphysis, new bone 
formation had proceeded to within less than 0.5mm of the cement. Nelissen et al., 
1995 reported on histology from four cases that had undergone femoral revision with 
impaction allografting and in whom the most proximal medial part of the femur had 
been biopsied during removal of trochanteric wires 11-27 months after revision 
surgery. Again, three zones were described: an inner zone comprising of necrotic 
bone and fibrous tissue; an intermediate zone with viable trabeculae (neocortex); and 
an outer zone with normal cortex and periosteum.
More recently, (Linder, 2000) reported on a histological analysis of 14 cases with 
duration o f 3-96 months after femoral cancellous impaction grafting. The histology 
varied considerably. Whilst the cortex showed complete reconstitution of viable 
lamellar cortical bone or ongoing revascularisation o f previously necrotic bone, the 
medullary cavity had a variable combination of trabecular bone, graft particles, 
fibrous tissue and necrotic graft. This study showed that the initial stage of graft 
ineorporation involved the invasion of the graft, from the periphery, by fibrovascular 
tissue. This stage did not involve a foreign body reaction. In some sections, avascular 
impacted graft was observed adjacent to the cement, signifying that the vascular 
invasion did not always reach the cement surface. Foreign body giant cells were seen 
on the surface of the tissue in contact with the cement, in cases where the fibrous 
tissue had reached the cement. New bone formation was only observed in cases where
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vascular invasion had taken place. Again three zones were observed; an inner zone 
consisting o f no viable bone but eomprised of either composite tissue or necrotic 
graft; an intermediate zone o f intense remodelling with osteoclastic resorption of the 
surface of graft granules and concomitant deposition of osteoid and bone; and an 
outer zone with cancellous bone and normal looking bone marrow.
(iii) Increased bone and blood flow formation in impacted morsellised allografts
Sorensen et al., (2003) used positron emission tomography (PET) to evaluate 
vascularisation and new bone formation in impacted morsellised allograft used in 5 
patients revised with femoral impaction allografting. Their results showed much 
enhanced bone formation and blood flow close to the allograft as early as eight days 
post surgery. Four months post-surgery, bone formation and blood flow were about 
the same, but activity was highest in the graft material. Blood flow within the graft 
bed reduced to levels of the un-operated femoral diaphysis about 1 year after the 
surgery.
(iv) Animal Studies
In a histological evaluation of impacted allografts surrounding hip prostheses in goats 
(Schreurs et al., 1994), revascularisation and remodelling of the graft and new bone 
formation from the cortex towards the cement mantle was observed at six and twelve 
weeks post surgery. Observations in the titanium chamber model in the rat (Tagil, 
2000) resemble those on the histological findings of human femurs (Linder, 2000) in 
that the fibrovascular tissue penetrates the graft almost completely, whilst new bone 
formation is more limited. Load bearing has been shown to favour bone formation in 
a rat tibial prosthesis model (Wang et al., 2000). The addition of OP-1 to impacted
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graft promotes bony ingrowth (Tagil et al., 2000) and bone graft incorporation 
(McGee et al., 2004), in an animal femoral impaction grafting model, proving that 
biological factors are important in impaction grafting. However, this was a small 
study using only four sheep, thus making it difficult to draw any real conclusions 
from it. Furthermore, mixing allograft with OP-1 did not improve cup or stem 
fixation in revision hip surgery in humans (Karrholm et al., 2006).
(v) Bone-fibrous tissue composite: biological and functional aspects
A recent study in a rat tibial chamber model (Tagil and Aspenberg, 2001) has shown 
that graft containing fibrous tissue was mechanically stronger than freshly impacted 
graft. This has lead to conclusions by some researchers (Aspenberg, 2001) that 
remodelling is not always necessary for a good clinical outcome and that perhaps a 
combination of necrotic bone and fibrous tissue may constitute an excellent 
biomaterial for revision surgery.
(vi) Mechanical studies of impacted allograft stability
As well as reconstituting bone stock, any form of grafting should also provide 
mechanical stability to prevent subsidence and failure of the construct. In vitro 
studies, using a fibreglass femoral model, have shown that the optimum chip size that 
produced the greatest stability was around 4-5mm. Other studies have shown that 
graft with a broad distribution of particle size exhibited superior mechanical 
properties compared with a graft of uniform size distribution (Tanabe et al., 1999; 
Brewster et al., 1999). It is noteworthy that bone mills in eurrent use in the UK, 
produce a distribution of particle sizes more uniform than is desirable for maximising 
resistance to shear stresses (Brewster et al., 1999).
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Mechanical properties of impacted allografts have also been shown to improve with 
increasing normal load, increasing shear strains, increasing compaction energy and 
with the addition of small and very small fragments (Brewster et al., 1999). Visco­
elastic materials exhibit stress-strain behaviour that is time- and rate- dependent, i.e. 
the material deformation depends on the load and its rate and duration of application. 
Creep is the term used to describe an increase in deformation or strain that occurs 
when a constant load is applied over an extended period (viscoelastic creep). The 
impacted graft has also been shown to exhibit visco-elastic properties (Giesen et al.,
1999) and laboratory studies have shown that this visco-elastic behaviour was 
affected by several factors. Firstly, reducing the water content and, more 
significantly, the fat content reduced creep and deformation of the graft (Voor et al.,
2000), Secondly, extraction of bone marrow from the bone graft increased stem 
stability by significantly reducing proximal-distal migration of the stem under loading 
(Hostner et al., 2001). Finally, a lower graft porosity and stiffer bone graft decreases 
the visco-elastic behaviour of bone grafts (Verdonschot et al., 2001). Biomechanical 
studies have shown significantly less stem subsidence in the impacted cortical 
morsellised graft compared with impacted cancellous graft (Kligman et al., 2002; 
Kligman et al., 2003).
1.7f Technique Vs System
Some reports of the impaction grafting technique (Eldridge et al., 1997; Elting et al., 
1995; Meding et al., 1997; Nelissen et al., 1995) imply it is a system requiring not 
just an exact surgical method, but also a particular implant, the polished double­
tapered stem. Others consider it a surgical technique and have varied the femoral 
component design (Hostner et al., 2001; Leopold et al., 1999), the method of graft
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delivery and any other elements of the procedure (Masterson et al., 1997). In the 
absence of randomised, controlled clinical trials to evaluate particular elements of this 
procedure, it is difficult to determine which are the crucial factors. However, 
investigators have shown similarly good short-term to medium-term results with 
various femoral stems at numerous centres (Morgan et al., 2004).
1.7g Graft incorporation
The process o f cancellous graft incorporation (or healing) is similar to that of fracture 
healing (Tagil et al., 2000) and is divided into three indistinct stages. Initially, a 
haematoma forms at the graft site, which is followed by an acute inflammatory 
reaction (Stage I). The clot attracts platelets, which release inflammatory mediators, 
which in turn recruit leucocytes and macrophages. In stage II, consolidation occurs 
whereby fibrovascular tissue invades the graft with subsequent recruitment of 
mesenchymal stem cells. These pluripotent stem cells differentiate into osteoblasts 
and osteocytes. Osteoclasts begin to resorb the graft whilst the osteoblasts begin to 
lay down the osteoid. Remodelling (Stage III) is mineralisation and further maturing 
of bone.
Cortical graft incorporation differs from that of cancellous grafts. Due to the dense 
structure of cortical bone compared with cancellous bone, cortical grafts remodel 
slowly and seldom completely. This process is initiated by an osteoclast-mediated 
resorption (creating cutting cones through bone) followed by fibrovascular stromal 
invasion and an osteoblast mediated laying down of new bone. Some reports indicate 
only 2-3mm of ingrowth in massive cortical allografts (Enneking and Mindell, 1991). 
Conversely, cancellous bone graft can be completely resorbed. The three dimensional
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and porous nature of cancellous grafts is conducive to osteoconduction, which 
eventually lays osteoid on trabeculae.
1.8 Bone graft substitutes
Due to the previously mentioned complications with the use of autografts and 
allografts, there has been increasing interest in the use o f bone graft substitutes to 
reconstitute bone loss encountered during revision hip surgery.
1.8a Demiueralised Boue Matrix
The use of demineralised bone matrix (DBM) is popular in the USA but it is used to a 
lesser extent in Europe. DBM is formed from autologus bone extracts consisting of 
non-collagenase proteins, bone growth factors and collagen. DBM is osteoconductive, 
moderately osteoinductive but offers no structural support (Gamradt and Lieberman,
2003). DBM becomes biologically inactive at room temperature after a few hours 
(Delloye et al., 2003). Ethylene oxide and radiation treatment reduces the 
osteoconductive potential (Delloye et al., 2003). Furthermore, often potentially 
nephrotoxic chemicals have to be added to the demineralised bone to enable handling 
and increase volume (Delloye et al., 2003).
1.8b Xeuografts
Although xenografts are commercially available, they are rarely used today due to the 
possible risk of transmitting zoonotic diseases and the lack of evidence supporting 
their ability to form living bone (Delloye et al., 2003).
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1.8c Hydroxy apatite
A variety of bone-graft substitutes, including titanium flbremetals, collagen, bioactive 
glasses and ceramics composed of hydroxyapatite (HA), tricalcium phosphate (TCP) 
or both, have also been used to overcome the problems that have arisen with bone 
grafts (Bucholz et al., 1987). HA and calcium phosphates have been shown to evoke a 
biological response similar to bone and show great potential as bone-graft substitutes, 
particularly in contained bone defects (Delloye et al., 2003). Furthermore, they can be 
readily moulded into desired sizes and shapes and the porous nature of these materials 
facilitates bony ingrowth. In addition, these materials are osteoconductive, 
biocompatible, easily sterilised, are not immunogenic and can be used when large 
amounts of bone graft are not available. However, disadvantages include a lack of 
osteogenic and osteoinductive potential and their limited ability to offer immediate 
structural support (Delloye et al., 2003; Bruder et al., 1998).
In non-human primates, hydroxyapatite is the only bone substitute agent which has 
demonstrated significant osteoinduction heterotrophieally on its own, without the 
addition of bone morphogenie proteins (BMPs) (Ripamonti, 1991; Ripamonti, 1992; 
Ripamonti et al., 1993; van Eeden and Ripamonti, 1994). It has been postulated that 
porous HA acts as a substratum for adsorption of endogenously produced BMPs, 
which then induce bone formation (Ripamonti, 1991; Ripamonti, 1992; Ripamonti et 
al., 1993; van Eeden and Ripamonti, 1994).
Oonishi et al. (1997) have reported their results on the use of granular HA to fill 
massive acetabular defects during revision total hip arthroplasty. These show that 
although on radiographs some spaces were observed at the interface between the HA 
granules and bone immediately post-surgery, they gradually disappeared within 3
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months, presumably because new bone entered the space between the granules 
encircling the cavity and became bound to them. Furthermore, sclerotic bone that had 
surrounded the loose cup was seen to change to the appearance of cancellous bone 
over a period of one to three years after revision.
1.8d Hydroxyapatite and impaction grafting
In vitro studies (Verdonschot et al., 2001) evaluating the mechanical properties of 
HA/TCP particles in relation to morsellised bone graft for use in impaetion grafting 
have shown that the biomaterial particles do not crunch or damage after impaction. 
Furthermore, the elastic and viscoelastic deformation of the biomaterials is minimal 
(Verdonschot et al., 2001). The initial stability of acetabular cups has also been 
shown to be augmented with the addition of TCP/HA particles in bone impaction 
grafting (Bolder et al., 2003).
1.9 Summary & Thesis Background
The need for revision hip arthroplasty will continue to rise for the foreseeable future. 
The principal aims of revision hip surgery are to achieve immediate fixation and 
long- term stability and to reconstitute bone loss. However, reduction of bone stock 
available for subsequent implant fixation probably accounts for inferior results 
attained in revision surgery compared with the primary procedure. The technique of 
femoral impaction allografting to reconstitute bone loss during revision hip surgery 
has shown excellent results. However, limitations with the use of bone grafts has 
warranted this research to investigate whether bone graft substitutes can be a 
comparable and suitable alternative to replace or augment allograft in impaction 
grafting.
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Hypothesis
This project will test the hypotheses that:
• The addition of hydroxyapatite (HA) in various combinations with allograft 
induces similar patterns of bone formation as allograft alone.
• The addition of mesenchymal stem cells (MSCs) to allograft or HA enhances 
the amount of new bone formation compared with impaction of the scaffold 
alone.
• The architecture of the HA scaffold influences the proliferation and 
differentiation o f MSCs.
Although this study will concentrate on femoral impaction grafting, the results should 
be relevant in the use of this technique for the acetabulum, as the two are interlinked.
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CHAPTER 2 
IMPACTION GRAFTING OF FEMORAL STEMS 
USING HYDROXYAPATITE (APAPORE)
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2.1 Introduction
Impaction grafting is a successful technique in reconstituting bone loss during 
revision hip arthroplasty. However, the numerous complications associated with the 
use of bone grafts, combined with the fact that demand for cancellous allografts may 
outstrip the supply in the future, has prompted research to investigate the use of bone 
graft substitutes (Silva et al., 2005; Pratt et al., 2002). One study (Silva et al., 2005) 
has highlighted the potential of porous hydroxyapatite to heal bony defects over 
cancellous bone graft at 24 weeks. The chemical composition and crystallographic 
structure of hydroxyapatite, similar to bone, makes it a stable, non-toxic material, 
whilst its macroporosity allows migration o f blood vessels and the ingrowth of bone 
tissue. It is believed that the poor structural integrity o f hydroxyapatite and inferior 
mechanical properties, in comparison to bone graft, limit its use in reconstructive hip 
surgery (Verdonschot et al., 2001). However, amalgamation with allograft bone in 
impaction grafting may present a number of potential advantages (Verdonschot et al., 
2001; Silva et al., 2005).
ApaPore 60 (Apatech Ltd) is a porous hydroxyapatite that has been chemically and 
structurally modified to optimise host bone ingrowth in impaction whilst maintaining 
structural integrity. It has a pore size of 230 pm and porosity of 60%. These granules 
have interconnected porosity with a macrostructure similar to cancellous bone. The 
large macropores facilitate angiogenesis and maintain long-term osseous integration 
(Eggli et al., 1988). Furthermore, deformation of the pores does not result in closure 
of the pores due to its large size. Its porous structure is consistent, providing a 
controlled macroporosity within +/- 1%, giving a much more predictable bony 
response. The struts are highly microporous and the microporosity is interconnected, 
which allows nutrient transfer to host bone and stimulates cell differentiation (Eggli et
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al., 1988). ApaPore has high levels of interconnectivity between micro and 
macropores. This network allows rapid bone ingrowth, promotes revascularisation, 
which is essential to healthy bone, enhances long-term graft stability and provides a 
continuous host bone/graft composite.
Actifuse (ApaTech Ltd) is a phase-pure 80% porous calcium phosphate material in 
which the phosphate groups have been selectively replaced with silicate ions. Studies 
have shown that silicon is a significant dietary trace element for healthy bone 
formation and remodelling (Carlisle, 1981; Schwarz and Milne, 1972). Silicon, 
released in vivo, is reported to enhance osteoblastic differentiation and stimulate the 
formation of bone tissue (Patel et al., 2002). Moreover the surface chemistry of 
Actifuse leads to enhanced adsorption and activation o f the proteins involved in 
osteogenesis, leading to much more rapid and better quality bone formation than with 
hydroxyapatite alone (Hing et al., 2006).
Besides an improvement of biomechanical properties, expansion or replacement of 
allograft with synthetic agents would have biological and economical advantages. 
Indeed, one of the current limitations of impaction grafting is that it relies on the use 
of allogenic bone. Substituting bone with synthetic granules would address the 
concerns over transmission of pathogens and shortage of supply (Galea et al., 1998).
2.1a Hypothesis
The use of ApaPore in various combinations with allograft and Actifuse will be 
biologically effective and functionally stable using a cemented impaction grafting 
technique in an ovine hemiarthroplasty model.
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2.1b Objectives
Hydroxyapatite has proven biocompatibility and the ability to act as an 
osteoconductive material and when combined with donor bone in a weight relation of 
50:50 reduces the required amount of donor bone by half (Verdonscbot et al., 2001; 
Moore et al., 1987; Buckland T. and Lawes P., 2002). However, similar results may 
be achievable with even higher concentrations of hydroxyapatite, thus reducing the 
amount of required allogenic bone. Additionally, silicate-substituted hydroxyapatite 
has been demonstrated to enhance osteoblastic differentiation and stimulate new bone 
formation compared with phase pure hydroxyapatite (Patel et al., 2002; Hing et al., 
2006). The objective of this study was to compare a 50:50 HA( ApaPore) : allograft 
mixture with higher concentrations by volume porous HA (ApaPore) with allograft 
and Actifuse for cemented impaction allografting o f the femoral stem. The four 
treatment groups used were:
Group 1: ApaPore: allograft mixed 50:50.
Group 2: ApaPore: allograft mixed 70:30.
Group 3: ApaPore: allograft mixed 90:10.
Group 4: ApaPore: Actifuse: allograft mixed 80:10:10.
The four treatment groups will be compared by examining:
a) The Ground Reaction Force (GRF) passing through both the 
operated and non-operated bind limbs pre-operatively and at 8, 16 and 
24 weeks post surgery. GRF results are a measure of implant function 
and bow well the animal uses its operated limb and a persistent
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reduction in function can be evidence of implant loosening. 
Furthermore, a failure to regain function after surgery implies that the 
loads passing through the implant and the associated micromotion may 
not be representative of a normal healing process which gives 
anomalous results in terms of bone ingrowth.
b) Mineral apposition rates (MAR) within each of the experimental 
groups. This will allow quantification of the rate of new bone 
formation within each of the groups, thus permitting comparison o f the 
osteogenic potential of the different bone graft substitutes.
c) The interface between graft material and tissue in the different 
experimental groups in the proximal, mid and tip region of the femoral 
stem and distal to the tip. As different areas of bone exhibit variable 
remodelling rates, new bone formation and percentage of remaining 
hydroxyapatite were measured in these sections.
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2.2 Methods
2,2a. Preparation of cancellous allograft and hydroxyapatite
Long bones were removed from healthy sheep that were euthanased as part o f an 
unrelated study. The bones were stored in double-layer polyethylene wrappings at a 
temperature of -20°C. All soft tissue and cartilage was removed and cancellous 
portions of long bones were cut into smaller pieces using a bandsaw and then 
morsellised using a bone mill' (Fig 2.1). This created morsellised chips between 3- 
5mm in diameter. A protocol devised by the Tissue Service of National Blood 
Service^ was followed for washing and defatting the graft (Table 2.1, Fig 2.1). The 
morsellised chips were stored in double-layered airtight polyethylene bags at a 
temperature o f-20°C  (Fig 2.1). HA granules (ApaPore 60^ "^  and Actifuse^'^) were 
obtained from ApaTech Ltd.
Step Procedure
1 1 x 1 5  minutes sonic water wash (hot tap water ~ 55°C)
2 - 4 3 x 1 5  minutes stirred water wash (hot tap water ~ 55°C)
5 1 X 60 minutes stirred water wash (hot tap water ~ 55°C)
6 1 x 1 0  minutes stirred and sonic 70% alcohol wash
7 - 8 3 x 1 5  minutes stirred water wash (hot tap water ~ 55°C)
Table 2.1: Protocol for washing and defatting allograft (devised by the Tissue 
Service o f National Blood Service)
' Lere Bone Mill, DePuy International, Leeds, UK
 ^North London Tissue Bank, Deansbrook Road, Edgware, Middlesex, HA8 9BD
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r
Figure 2.1: Allograft preparation: morcellising in Lere Bone Mill (A), washing in 
sonic water wash (B) and storage in double-layered airtight polyethylene bags (C).
2.2b Graft Irradiation
Allograft and HA samples were sterilised by gamma irradiation at a dose of 30-35 
KGrays'. Allograft was stored in dry ice when transported for sterilisation and the 
irradiated allograft was returned to our laboratory within 48 hours, where it was 
stored at -20°C.
2.2c Graft preparation
Using stocks of allograft and HA, four treatment groups were produced for 
implantation (see below). Randomisation of allocation allowed comparison between 
treatment groups. Six animals in each group were investigated.
Group 1: ApaPore: allograft mixed 50:50.
Group 2: ApaPore: allograft mixed 70:30.
Group 3: ApaPore: allograft mixed 90:10.
Group 4: ApaPore: Actifuse: allograft mixed 80:10:10.
Isotron, Reading, UK
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2.2d Femoral stem design
Femoral impaction grafting was performed with a custom designed’ collarless, 
polished, double-tapered, Vitallium^ cemented stem and antibiotic impregnated 
cement.
2.2e Surgical procedure
All procedures were carried out in compliance with Home Office regulations (Animal 
Scientific Procedures Act (1986)). Twenty-four skeletally mature female 
commercially cross-bred sheep weighing between 65 and 80kg and aged between 2 
and 5 years were used. The animals were individually housed in pens, forty-eight 
hours prior to the surgery. Only fluid intake was permitted twelve hours before the 
operations. Premedication constituted o f an intramuscular injection o f 2% Xylazine 
Hydrochloride solution (Bayer PTC, Germany) at a dose o f 0.2mg/kg, administered 
30 minutes before anaesthesia. Induction of anaesthesia was achieved with an 
intravenous bolus of 2mg/kg Ketamine and 2.5mg Midazolam mixed with Xylazine 
(Roche Products, UK) into the left jugular vein and maintained by inhalation of 
Halothane (Meriel Animal Health Ltd) and oxygen via an endotracheal tube. 
Buprenorphine (0.6mg) (Reckitt and Coleman Products Ltd) was given 
intramuscularly as an analgesic at 10-20 pg/kg. Antibiotics (lOmg/kg ceftiofur, 
Pharmacia, Northampton, UK) were administered subcutaneously at anaesthetic 
induction and repeated once daily for three days. Vital signs (heart rate, blood 
pressure, respiratory rate and oxygen saturation) were monitored throughout the
’ Stanmore Implants Worldwide, Centre for Biomedical Engineering (UCL), Royal National 
Orthopaedic Hospital Trust, Brockley Hill, Stanmore, Middlesex. UK
 ^Cobalt Chromium alloy
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operative procedure. A gastric tube was inserted at induction to prevent abdominal 
bloating, regurgitation and reflux of the rumen contents.
In the anaesthetic room, a large area over the antero-lateral aspect of the right hip was 
shaved and thoroughly cleaned with Povidine solution. Before commencing surgery, 
the operative area was further cleaned with a sterile swab soaked in chlorhexidine 
solution and wiped along the line of the proposed incision, gradually extending 
across the cleaned area centrifugally in ever-widening circles so that the incision line 
was not contaminated with a swab that has touched skin at the periphery. Sterile skin 
towels were applied to isolate the incision line and held together with towel clips.
The animals were placed in a left lateral recumbancy position on the operating table 
in order to gain exposure to the right hip. The hip joint was exposed through an 
antero-lateral approach and the gluteal muscles detached partially from the femur. A 
T-shaped capsulotomy was performed and the femoral head dislocated, then resected. 
Cancellous bone within the proximal femur was removed using a curette until the 
largest impactor was able to pass into the femur. A centralising guide wire was 
attached to the restrictor and the distal graft was impacted in place using modified 
Exeter impactors that fitted over the guide wire. The femoral canal was blocked using 
a bone plug positioned at least 20 mm distal from the anticipated position of the stem 
tip and a guide wire screwed into the bone plug, which ensured central compaction of 
the graft. Prior to insertion, the relevant volumes of ApaPore granules and allograft 
were mixed in blood taken from the jugular vein and allowed to clot. Once 
coagulated, the mixture was inserted and impacted within the femur (Fig 2.2). The 
graft was then impacted into the walls of the femur using a series of phantom stems 
which were inserted over the guide wire, ensuring correct rotational alignment. After
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the final phantom and guide were removed, the cavity was filled with surgical grade 
Simplex bone cement. The Exeter styled implant, fitted with a plastic cap to prevent 
tip loading, was inserted into the cement. In all cases a 25mm diameter femoral head 
was used. The hip joint was reduced and the soft tissues closed in layers with an 
absorbable suture.
Figure 2.2: A mixture of ApaPore; allograft set in coagulated blood prior to insertion 
into the femoral canal.
Postoperatively, animals were allowed to fully weight-bear as tolerated. Antibiotic 
and analgesic prophylaxis was administered daily with subcutaneous injections of 
Baytril (Enrofloxacin 5mg/kg; Bayer AG Leverkusen) and Finadyne (Flunixin 
Meglumine 2mg/45kd; Schering-Plough Ltd) and continued for 3 days post-surgery. 
Animals were kept in individual pens for 4 weeks following the procedure before 
being group housed. All sheep were euthanased 6 months after surgery with an 
overdose of intravenous Pentobarbitone (50ml of 20% solution). The femur was 
harvested through the old incision.
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2.2f. Fluorescent Bone Marking
Fluorescent bone markers allowed quantification of new bone formation. They were 
administered on day 28 and at 2, 3 and 5 months post-surgery. Mineral apposition 
rates in bone adjacent to the femoral component were compared in the different 
experimental groups. Prior to staining for histological analysis, thin sections were 
observed using fluorescence microscopy and pictures taken of the fluorochrome 
labelled lines. Mineral apposition rates (mmday^) were calculated by measuring the 
distance between the cement lines and dividing by the magnification of the 
microseope and the number o f days between doses.
2.2g. Ground Reaction Force (GRF)
Animals were walked over a piezoelectric force plate (Kistler) preoperatively and at 
8, 16 and 24 weeks post surgery. Twelve readings o f maximum force (Fmax, N/m^) 
were taken for the right and left lower limbs of each animal. Average values of right 
(AR) over left (AL) limbs were calculated as a percentage (%AR/AL) and represent 
how well the animal used its operated limb, whereby 100% represents full weight­
bearing. Preoperatively, only animals with an AR/AL within the 95-105% range 
were included in the study and all values were normalised.
2.2h. Radiographic Analysis
Each hip joint was radiographed immediately postoperatively, at 8 and 16 weeks post 
surgery and following sacrifice.
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2.2i Histological analysis
Immediately after retrieval, samples were placed in 10% formaldehyde^ then 
dehydrated using ascending concentrations of methylated spirit^ and defatted using 
chloroform^ and finally embedded and east in LR white resin'^ (Table 2.2). Once cast, 
the micro sections (~150-200pm thick) were cut using the Exakt Diamond edge 
cutting saw^ (Type 310CP) using a 0.3mm thick blade. Technovit Glue was used to 
stick the thick sections to a Perspex slide (~ 4 mm thick). Thin sections (~70pm 
thick) were prepared using an Exakt micro grinding system^ through four regions of 
the femur: the proximal, mid and tip of the femoral component region and one distal 
to the implant tip (Figure 2.3). Sections were polished on the Motopol 2000 system^ 
with polishing cloth and 0.5pm Alumina polishing solution. Once prepared, the 
sections were stained with Toluidine Blue (to stain cell nuclei) for 20 minutes and 
Paragon (to stain new bone) for 25 minutes. To preserve the slides, cover slips were 
placed over the section using a Pertex mounting medium.
Figure 2.3: A radiograph demonstrating where each 
femoral implant was sectioned for histological 
analysis.
n
BDH laboratory ; Agar Scientific Ltd
Exact, Apparateban GMBH Robert-Koch-Strusse 5, D-22852 Nordestedt; ® Buehler Ltd
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Process Number of days
10% buffered formal saline 7
50% IMS 50% distilled water 3
70% IMS 30% distilled water 3
100% IMS (repeat step 3 times) 3
Chloroform (repeat Step twice) 1
100% IMS (change IMS twice per day) 3
50% LR white resin 50% IMS 7
100% LR white resin (under vacuum) 14
Cast in LR white resin (1 drop accelerator/10ml resin)
Table 2.2: Histology Processing Protocol
Images of each thin section were captured using a CCD digital camera and processed 
using the KS300 Image Analysis Software Package (Imaging Associates, Zeiss, UK). 
Using the lesser trochanter as a guide, four quadrants were measured in each section 
(Fig 2.3). Within these quadrants, the following parameters were calculated (using x4 
objective lens):
• Cement mantle thickness (at 8 equidistant sites) (Fig 2.4)
• Area of ApaPore (Fig 2.5)
• Area of new bone (Fig 2.5)
• ApaPore-bone contact (Fig 2.6)
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Figure 2.4: Calculation of cement mantle thickness using the KS300 software.
, > 'l  1 0 0  m i c r o n s
Figure 2.5: Calculation of area of new bone formation and remaining ApaPore. Only 
areas as demarcated by the green line were measured. All images were analysed on 
x4 magnification where the full screen size was 1.4mm^.
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Figure 2.6: Quantification of bone-ApaPore contact. At each relevant intersection on 
the grid it was noted whether bone or fibrous tissue was in contact with the ApaPore 
surface.
2.2j. Scanning Electron Microscopy (SEM)
Prior to staining, thin sections were sputter-coated with a layer of gold palladium and 
viewed using back scattered electron microscopy in a scanning electron microscope 
(Jeol 5500LV scanning electron microscope (Zeiss, Germany)). Only the distal 
sections from each animal in each experimental group were assessed using this 
technique.
2.2k. Statistics
All data collected from the study was analysed using the SPSS (vlO .l) statistical 
software package. A Kolmogorov-Smimov test revealed the data to be non- 
parametric and the Mann Whitney U test was used to compare results between the 
different experimental groups. The significance level was set at p< 0.05 in all tests.
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2.3. Results 
2.3a. Ground Reaction Force
All pre-operative results were normalised to the average % AR/AL (mean: 100.82 ± 
0.63). There was no significant difference in GRF values, when each of the four 
experimental groups were compared with each other preoperatively or at 8, 16 and 24 
weeks post surgery. However, there was a significant decrease in limb function in 
Groups I, 2 and 4 compared with preoperative values at 8 and 16 post-surgery, but 
this had improved by 24 weeks (Table 2.3, Fig 2.7). Function was not significantly 
affected in Group 3 at any time point.
Figure 2.7
A COMPARISON OF GRF DATA COLLECTED AT 8,16 AND 24 WEEKS 
POST-SURGERY (Values are Normalised)
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Group
16 week results 24 week results
Mean p value mean p value
1 93.09 ±3.33 0.021 94.55 ±2.99 0.035
2 92.14 ±1.87 0.001 92.93 ±1.87 0.006
4 81.30 ±6.81 0.001 87.53 ±6.33 0.021
Table 2.3: GRF (mean) at 16 and 24 weeks post surgery compared with pre-operative 
values. The signifieanee level was set at p< 0.05.
2.3b. Radiography
Anterior-Posterior (AP) and medial-lateral radiographs o f retrieved femora 
demonstrated that all implants were surrounded by densely impacted bone graft 
substitute. This is important because if the graft material did not surround the stem, 
the model may be compromised as the cement could integrate with host bone and not 
the graft.
The purpose of performing serial radiographs during the study was to measure 
subsidence. However, the radiographs varied in terms o f quality and uniformity 
which made comparison between serial radiographs difficult. Due to the inability 
therefore to accurately measure any potential prosthesis migration, the radiographs 
were not analysed for subsidence. However, on scrutinising the radiographs, all 
implants appeared to be well fixed with no obvious signs of subsidence (Figs 2.8 & 
2.9). Microradiographs of transverse sections through the proximal femur revealed 
impacted graft material surrounding the stem and bone cement (Figure 2.10). Similar 
radiographs distal to the stem tip showed the intramedullary cavity within the tubular 
cortical bone to be packed with graft material (Fig 2.11). There was no evidence of 
cement penetration into the graft at this level.
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Figures 2.8 & 2.9: (a) Anterior-Posterior and (b) medial-lateral radiographs of 
proximal and distal femur 6 months following insertion of 70:30 ApaPore: allograft 
mixture.
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Figure 2.10: Microradiograph of a transverse seetion through the proximal femur 
demonstrating impacted graft material (80:10:10) surrounding the stem and bone 
cement.
f
Figure 2.11: Microradiograph in the region distal to the stem tip showing impacted 
graft material (90:10). Intramedullary cavity surrounded by the tubular cortical bone 
(C) is filled with graft (G).
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2.3c. Fluorescent Labelling
Mineral apposition rates were calculated in mmday ' and values were compared 
between the four experimental groups. Cement lines were evident separating newer 
areas of bone and the markers were incorporated into both remodelled Haversian 
systems, in a regular concentric centrifugal manner, and in areas of bone where 
layered appositional growth had occurred (Fig 2.12).
Figure 2.12: Fluorescent labelling demonstrating cement lines separating new areas 
of bone formation.
Qualitative observation demonstrated that in each of the treatment groups, mineral 
apposition was greatest at the periphery, at the endosteal surface of bone, and least 
towards the cement surface. Results from fluorescent markers within the graft 
material demonstrated significantly greater bone formation rates in Group I compared 
with the other three groups (Fig 2.13). There was significantly less bone formation in 
Group 4 compared with the other three groups (Table 2.4). However, variations in 
mineral apposition rates were noted within the different regions of the femur. There 
was significantly high mineral apposition rates seen in the distal region in Group 1 
compared with group 2, but not any other group (Fig 2.14). No significant differences 
were observed in any of the other regions when the four groups were compared.
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Figure 2.13
A COMPARISON OF MINERAL APPOSITION RATES (MAR) IN ALL REGIONS IN EACH
EXPERIMENTAL GROUP
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90:10 p<0.05 0.108
80:10:10 p<0.05 P<0.05
Table 2.4: Comparison of mineral apposition rates between the four treatment 
groups (p<0.05 considered to be statistically significant).
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Figure 2.14
A COMPARISON OF MINERAL APPOSITION RATES (MAR) IN THE 
PROXIMAL, MID, TIP AND DISTAL REGIONS IN ALL EXPERIMENTAL GROUPS
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2.3d. Cement Mantle Thickness
There was no significant difference in cement mantle thickness amongst the four 
experimental groups or when the same region of the femur was compared within the 
four groups (Fig 2.15). However, a significantly thinner cement mantle was noted in 
the proximal regions of all the groups (p<0.05) when compared with the ‘mid’ region 
where the thickest cement mantle was identified, except in Group 2 (Fig 2.16).
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Figure 2.15
A COMPARISON OF CEMENT MANTLE THICKNESS IN ALL REGIONS
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Figure 2.16
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2.3e. Area of HA Granules
All images were analysed on x4 magnification within a defined field measuring 
1.4mm^. Overall, there was significantly more bone graft substitute in Group 3 (0,683 
±0.052mm^) compared with Group 4 (80:10:10) (0.5446 ±0.0224mm^), but not the 
other three groups, and this was not confined to any particular region (Fig 2.17). 
Otherwise, no significant difference was found in any of the regions amongst the four 
groups. In each of the experimental groups, there appeared to be a general trend 
demonstrating the presence of HA granules in the proximal and distal regions 
adjacent to the implant (Fig 2.18).
Figure 2.17
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Figure 2.18
A COMPARISON OF BONE SUBSTITUTE AREA IN THE PROXIMAL, MID, TIP 
AND DISTAL REGIONS IN ALL GROUPS
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2.3f. Bone Area
Overall, there was significantly more bone present in Groups 1 and 3 compared with 
Group 4 (Fig 2.19, Table 2.5) but not Group 2. Within all the groups, the majority of 
the bone was observed in the proximal and distal regions of the stem and the least in 
the mid and tip regions (Fig 2.20). In the proximal region, significantly less bone was 
seen in Group 4 (0.449 ±0.040mm^) compared with Group 2 (0.652 ±0.053mm^ 
(p=0.003)) and Group 3 (0.713 ±0.059mm^ (p=0.003)). In the distal region, 
significantly more bone was quantified in Groups 1 (0.703 ±0.049mm^) and 3 (0.817 
±0.047mm^) compared with Groups 2 (0.407 ±0.053mm^) and 4 (0.396 ±0.055mm^) 
(Table 2.6). In the mid and tip areas, there was no significant difference in bone area 
in any of the groups.
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Figure 2.19
A COMPARISON OF TOTAL BONE AREA IN ALL REGIONS IN ALL GROUPS
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P<0.05 P<0.05P<0.05
Table 2.5: Comparison of amount of bone within the graft between the four groups
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Figure 2.20
A COMPARISON OF TOTAL BONE AREA IN THE PROXIMAL, MID, TIP AND 
DISTAL REGIONS IN ALL GROUPS
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P<0.05
0.757 P<0.05
Table 2.6: Comparison of bone presence in the distal stem amongst the 4 groups 
2.3g. Bone-Bone Substitute Contact
There was significantly increased bone-bone substitute contact in Groups 1 (82.592% 
±1.053) and 3 (81.534% ±1.571) compared with Groups 2 (61.716% ±3.268) and 4 
(66.662% ±2.329). However, no significant differences were identified when Groups 
1 and 3 or Groups 2 and 4 were compared. Similarly, no significant difference was
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demonstrated within any of the groups when %Bone-Bone substitute contact was 
measured in a proximal to distal direction along the length of the femoral stem (Figs 
2.21 & 2 .22).
Figure 2.21
COMPARISON OF %BONE-BONE SUBSTITUTE CONTACT IN ALL
REGIONS IN ALL GROUPS
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Figure 2.22
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2.3h. Backscattered Scanning Electron Microscopy
Backscattered scanning electron microscopy identified bone growth from the 
endosteal surface of the bone into and within HA granules within the medullary canal 
(Fig 2.23). Haversian systems were observed adjacent to HA granules which had 
remodelled within mature lamellar bone. In addition, in all groups, bone was 
identified in contact with the outer surface of the HA granules and also within pores 
(Fig 2.24).
GRANULES
2.23a
Figure 2.23: Backscattered scanning electron microscopy showing new bone formation: (a) 
bone growth from the endosteal surface into and within the HA granules within the medullary 
canal and (b) Haversian systems (arrows) adjacent to HA granules which had remodelled within 
mature lamellar bone. Fracture lines within the HA granules are clearly visible.
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Figure 2.24: Backscattered scanning electron microscopy images showing bone 
in contact with the outer surface o f HA granules and also within pores.
2.31. Histology
Histology showed complete reorganisation of the intramedullary canal. The implant 
stem was surrounded by a layer o f cement, which in turn was surrounded by HA 
granules around which new bone had formed. The existing cortex was evident. 
Histological analysis of specimens in all groups demonstrated abundant bone growth 
in direct contact with ApaPore/Actifuse and forming a network of mature lamellar 
bone adjacent to the implant and within the medullary cavity (Figs 2.25 & 2.26). 
Broken particles of HA were also seen, but were embedded within bone. In many 
instances, bone lamellae within pores were centripetally organised. Blood vessels 
were also observed within the pores and were often located centrally and surrounded 
circumferentially by lamellar bone. The cement interface was inter-digitated with 
both bone and HA particles. At this interface, HA granules were seen either in direct 
contact with cement or separated from it by a thin layer o f bone. Small amounts of 
allograft placed adjacent to the implant during surgery could be identified in localised
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areas, providing a scaffold onto which new bone grew (Figs 2.26 & 2.27). 
Histological examination demonstrated fragmentation of HA granules in some 
specimens within each of the experimental groups. In all specimens where 
fragmentation had occurred, an inflammatory-like reaction with densely stained 
mononuclear, multinucleated and macrophage-like cells were present, along with a 
fibrous tissue interface separating HA granules from the bony surface (Figs 2.28 & 
2.29). Sub-mieron sized particles had been engulfed by macrophages and foreign 
giant cells.
- A .»
Figure 2.25: Histological analysis of specimens (low power); photomicrograph 
showing stem (S) cement (C) and cortical bone (Cb) with new intramedullary bone 
formation (B) between the HA granules (A)
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Figure 2.26: A photomicrograph (a) low power and (b) high power demonstrating 
mature bone surrounding HA granules within the medullary canal.
. . ‘ ^
Figures 2.27: Photomicrographs (a) low power and (b) high power showing the HA- 
cement interface. HA particles are separated from the cement (C) by a thin layer of 
bone (B) or are in direct contact with the cement (arrow).
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Figure 2.28: Photomicrograph showing allograft and newly formed bone.
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Figures 2.29: (a) x20 (b) x40 and (c) x80 magnification micrographs of fragmented 
HA granules showing how particles of HA are released from around the edges of the 
HA granules. This produces a histiocytic response where particles are phagocytosed 
by macrophages. Particle release occurs only where there is a soft tissue interface (si) 
and not where new bone is in direct contact with the HA granules.
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2.4. Discussion
An ovine hemiarthroplasty model was selected for this study because the sheep femur 
is known to be tubular with minimal cancellous bone and poor blood supply, making 
it a suitable experimental model which resembles the bone stock encountered in a 
clinical revision situation (Goel et ah, 1982; Eitel et al., 1981). The hip forces in the 
sheep correlate well with those in the human (Bergmann et al., 1984) and thus, 
functional loading of the graft-composite would be similar to those encountered in the 
clinical setting. Furthermore, the primary ovine hip replacement model has previously 
successfully been used to investigate a revision scenario (Blom et al., 2005; McGee et 
al., 2004). However, there may be aspects of the tissue environment prior to revision 
hip surgery, in humans, that are not represented in this model i.e. endosteal erosions, 
residual inflammatory tissue and compromised host bone quality (Verdonschot et al.,
2001). The inability, therefore, to recreate with complete accuracy the tissue 
environment encountered during revision hip surgery remains a limitation of this 
study.
Results from this study confirmed the osseoconductive properties of HA granules. 
Histological and backscattered SEM analysis of specimens in all groups demonstrated 
a remodelled endosteal surface with abundant bone growth in direct contact, within 
and around HA granules, forming a network of mature lamellar bone adjacent to the 
implant and within the original medullary cavity. Post-mortem radiographs showed 
implants surrounded by densely packed graft material and ground reaction force data 
demonstrated functional hips in all cases. All animals were able to use their operated 
limb immediately post-surgery and during the course of the experiment. Although 
there was an initial decrease in limb function in Groups 1, 2 and 4, this improved by
106
CHAPTER 2
24 weeks. Function in Group 3 (90:10) was not significantly affected at any time 
point. GRF results are a measure of implant function and how well the animal used its 
operated limb and a persistent reduction in function can be evidence of implant 
loosening.
Analysis o f cement mantle thickness did not reveal any significant difference 
amongst the tested groups. Cement mantle was thickest in all groups (except Group 
2) in the ‘mid’ region o f the femoral component when compared with the proximal 
and tip regions. Cement mantle was not observed distal to the stem tip in any of the 
groups. These results are supported by a recent study (Frei et al., 2004) which 
investigated the graft-cement-host bone interface after impaction allografting of a 
femoral component in human cadaveric femora and showed significantly increased 
cement mantle thickness in the ‘mid’ region, with absence o f cement mantle distal to 
the stem tip. The study concluded that although cement-endosteal surface contact 
enhanced the allograft-cement composite-host bone interface strength, it was 
significantly weaker compared to a primary THR. The authors suggested that the host 
bone interface may be enhanced by postoperative allograft remodelling, which may 
be the key to the success of the impaction allografting technique.
In all groups, the cement interface was inter-digitated with both bone and HA 
particles. At this interface, HA granules were seen either in direct contact with 
cement or separated from it by a thin layer o f bone. Bone particles within the cement 
mantle may give rise to cement or bone-cement composite fractures which have been 
associated with subsidence of the stem (Masterson et al., 1997). However, Dai et al. 
(1991) have shown that bone particles embedded in cement can be replaced by new
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bone and form a viable cement-bone interface. In that study the strength of this viable 
interface was significantly higher than cement alone, but it is not known whether 
these findings are applicable to impaction grafting.
The administration of fluorescent bone markers allowed quantification of mineral 
apposition rates and results demonstrated significantly greater bone formation in 
Group 1 (50:50) compared with the other groups. Other authors have supported 
similar findings (Moore et al., 1987; Virolainen et al., 1997). A study by (Pratt et al.,
2002) comparing impaction grafting with allograft and allograft-80%: HA-20% TCP 
showed larger quantities o f new bone within the allograft only group. However, in 
this study we have shown that allograft mixed with up to 90% HA has similar 
integration and osseoconductive properties as allogenic bone and this has significant 
clinical implications in terms o f allograft savings.
The bioactivity of hydroxyapatite has been shown to be significantly enhanced with 
the incorporation of silicate ions into the hydroxyapatite structure (Gibson et al., 
1999). Furthermore, silicate-substituted hydroxyapatite has been demonstrated to 
enhance osteoblastic differentiation and stimulate new bone formation compared with 
phase pure hydroxyapatite (Patel et al., 2002; Hing et al., 2006). However, in this 
study mineral apposition rate and new bone formation was significantly lower in 
Group 4 (80:10:10) compared with Group 3 (90:10). It therefore appears that the 
impaction process alters the mechanical and biological properties of silicate- 
substituted hydroxyapatite differently to that of phase pure hydroxyapatite. It may be 
that the Aetifuse particles crunch under impaction or deform elastically and are
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damaged to a significant level. In-vitro studies evaluating the time dependent 
mechanical properties o f Aetifuse would provide answers to this question.
To minimise the disparity in impaction grade, all specimens were prepared and 
manually impacted by the same person. There may be discrepancies in the impaction 
grade between the groups due to the effects of variable particle size distribution and 
the reduced compressibility o f hydroxyapatite compared to allograft on the level of 
impaction (Verdonschot et al., 2001). Deformation and intergranular motion can 
occur during compaction which can alter the impaction grade. Verdonschot et al., 
(2001) report that the particle size and porosity are important factors in total 
deformation, with less deformation exhibited in the biomaterial particles than in 
human bone graft. The degree of compaction of the graft is vital to the likelihood of 
bone incorporation and stability of the implant and will determine the strain of the 
graft (Malkani et al., 1996). Masterson et al. (1999) stated that the level of impaction 
is more important than stem design to the success of an implant. Only after adequate 
impaction is the morsellised graft strong enough to carry load (Masterson et al., 
1997). Hydroxyapatite, when manufactured in particulate form, can be harder than 
morsellised cancellous bone. Although this may affect the ease with which HA can be 
impacted, ultimately this will improve compaction and enhance implant stability. 
Pratt et al (2002) have discussed the possibility that better impaction and compaction 
of the graft and the resultant cohesion may compromise neovascularisation and 
incorporation of the graft; adequate vascular supply is an essential factor in 
osseointegration. A lower impaction grade may allow and encourage ingrowth of 
vessels and new bone. A firm impaction technique is crucial in achieving maximal 
graft-host bone contact. An advantage of using bone substitutes like ApaPore is that.
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providing that the granules do not collapse, the porosity is engineered in. Histology 
from our study showed that although there was evidence of fracture of the granules, 
there were also numerous pores through which blood vessels had penetrated. 
Increased microporosity of scaffolds has been shown to elicit rapid 
neovascularisation, essential for osseointegration (Virolainen et al., 1997). Allografts 
possess only limited osteoinductive capacity (Vaccaro, 2002) and as this study has 
shown, this does not appear to be that important as the different groups in this study 
gave similar results.
The biological and mechanical response of biomaterials, including HA, may be 
affected by particle size and porosity (Verdonschot et al., 2001). Our study utilised 
HA granules with 60% porosity. Further studies looking at the different available 
porosities of HA (70% and 80%) with variations in particle size would provide a 
greater insight into how these variables affect the biological and mechanical response.
A study by Buckland & Lawes (2004) comparing the use of allograft alone with 
50:50Allograft in impaction grafting demonstrated that the 50:50 group had 50% 
greater mechanical stability, 50% decrease in subsidence and a significant reduction 
in the variability of the mechanical properties o f the graft material. Our study has 
shown that similar results can be achieved with up to 90% ApaPore. Given these 
encouraging results impaction grafting using 100% HA granules can be investigated.
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6. Conclusion
Results demonstrated a successful ovine hemiarthroplasty model for hip 
impaction with well fixed implants observed 6 months post surgery with no 
obvious signs of loosening or subsidence.
Hips maintained functional stability throughout when higher amounts o f HA 
mixture were used, with no significant differences identified between 
experimental groups when limb function was assessed and compared.
Significantly higher mineral apposition rates were demonstrated in Group 1 
(50:50) and significantly lower values in Group 4 (80:10:10). This may be due 
to the impaction process altering the mechanical and biological properties of 
Aetifuse.
No significant differences between any of the experimental groups 
investigated were identified when cement mantle thickness data was 
compared. In all groups except group 2 (70:30), the thickest cement mantle 
was observed in the ‘mid’ region of the femoral component.
No significant differences in the area o f HA granules were identified in any of 
the groups, except between Groups 3 (90:10) and 4 (80:10:10). Generally in 
all groups, HA area was increased in the proximal and distal regions of the 
stem.
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Significantly increased bone area was measured in Groups 1 (50:50) and 3 
(90:10) compared with Groups 2 (70:30) and 4 (80:10:10). No significant 
difference was identified between groups 1 and 3. However, significantly less 
bone was measured in Group 4. Overall in all groups, bone area was higher in 
the proximal and distal regions of the stem.
Results from this study have clearly shown HA granules to be a suitable bone 
substitute to augment allograft and perhaps replace it in impaction grafting of 
a femoral component. Conversely, the use of Aetifuse in impaction grafting 
cannot be advocated at the present time. However, a silicon substituted 
ApaPore or 60% porous Aetifuse could be more biologically active than the 
Aetifuse used in this study and this theory warrants further investigation.
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CHAPTER 3
THE EFFECT OF MESENCHYMAL STEM CELLS 
ON THE INCORPORATION AND 
REMODELLING OF IMPACTION GRAFTING
113
CHAPTER 3
3.1a Introduction
As advances in molecular biology are made, there has been a gradual move from a 
tissue approach to a more cellular approach in providing a more efficient means o f 
reconstituting bone stock. Bone marrow contains a population o f cells capable o f 
differentiating into bone, cartilage, muscle, tendon, and other connective tissues. 
These cells, referred to as mesenchymal stem cells (MSCs), have been isolated from 
fat, muscle, periosteum and bone marrow (Dennis et al., 1992; Haynesworth et al., 
1992). Furthermore, techniques for directing the commitment o f MSCs into bone cell 
lineage have now been developed (Jaiswal et al., 1997; Haynesworth et al., 1992). 
Although, only about 1 in 100,000 nucleated cells are stem cells in the marrow 
(Friedenstein et al., 1987), in-vitro expansion over one-billion fold is possible and 
produces cells without a loss in their osteogenic potential (Bruder et al., 1998). At our 
Institution, sheep MSCs have successfully been differentiated into adipocytes, 
chondrocytes and osteoblasts (Kalia et al., 2006) and studies have demonstrated 
increased bony contact and in-growth to massive endoprostheses when the implant 
was sprayed with autologous MSCs (Kalia et al., 2006).
One possible approach to solve the problem o f reduced bone stock in revision 
arthroplasty is to implant MSCs directly to the site o f the bone defect. The tissue- 
specific differentiation o f MSCs in a eontrolled manner is vitally dependent on the 
matrix or local environm ent in which the MSCs reside (Caplan, 1990). An ideal 
matrix carrier needs to fulfil certain criteria (Bruder et al., 1998): it should permit 
loading and retention o f MSCs; it should have osteoconductive, osteoinductive and 
osteogenic properties; it should be made up o f materials normally found in the bone- 
tum over cycle; it should provide immediate strength and support; it should have a
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porous structure for stem cells to grow and for blood vessel invasion; it must persist 
for a sufficient period at the implantation site to maintain and release bioactive cells, 
but at the same time be biodegradable to prevent any deleterious effects o f the 
residual carrier on new bone formation.
Hydroxyapatite (HA) has been shown to be a good scaffold vehicle because o f its 
porosity, high biocom patibility and osteoconductivity (Vaccaro, 2002; Harris and 
Cooper, 2004; Cooper et al., 2001). Allograft has osteoinductive and osteoconductive 
potential and is an excellent scaffold. Both matrices support bone formation by acting 
as a scaffold for angiogenesis, cell recruitment, and ultimately osteogenesis by host 
cells (Cornell and Lane, 1998). Thus, a composite graft can be formed from the 
osteoconductive matrix o f  an allograft and/or HA combined with mesenchymal stem 
cells (MSCs), which provide osteoinductive and osteogenic properties. In this way, 
the allograft and/or HA acts as a delivery system and scaffold for the bioactive MSCs, 
allowing the passage o f osteoblast progenitor cells to the graft site and facilitating 
bony ingrowth.
HA loaded with M SCs have been reported to have a similar osteogenic potential to 
autogenous particulate cancellous bone and marrow (Yoshikawa et al., 1998; Boo et 
al., 2002). MSCs loaded onto a porous hydroxyapatite/tricalcium phosphate 
(HA/TCP) scaffold have been shown to regenerate bone in a large segmental femoral 
defect in rats (Kadiyala et al., 1997). By 8 weeks, more than 40% bone fill was 
achieved compared with only 10% of fill in cell free samples and 17% fill in samples 
loaded with fresh marrow only. Similar results have been observed with human 
MSCs, loaded onto a porous HA/TCP cylinder, implanted into osteoperiosteal 
segmental defects in the femur o f adult athymic rats (Bruder et al., 1998).
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Furthermore, in the latter study, all oF the MSC loaded samples produced 
uninterrupted bone marrow formation between the two ends o f the implant, whereas 
all the cell-free samples showed bone formation only at the bone/ceramic interface. 
Similar results reproduced in dogs, has proved that this technology is transferable to 
larger animals, and that the application o f this technique to humans is feasible 
(Bruder et a f , 1998; Kon et al., 2000).
Intra-operative m easurem ent o f forces during femoral impaction allografting in 
revision hip surgery have shown a range o f 3 to 9 kN (Phipps et al., 2002) with the 
majority o f the im pactions being between 3 to 6 kN. In vitro, stem cells are able to 
survive impaction forces o f up to 6kN with full recovery within eight days (Korda et 
al., 2006).
3.1b. Hypothesis
The addition o f M SC ’s to allograft or hydroxyapatite by impaction grafting will 
enhance the amount o f new bone formation when compared with impaction o f 
allografts or HA alone in an un-cem ented ovine model.
3.1c. O bjectives
The objectives o f this study were to assess the contribution o f stem cells to the 
material properties o f new bone/ graft composite using defect densitometry and 
histomorphometric analysis.
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3.2 M ethods 
3.2a. Preparation o f cancellous allograft and HA
Long bones were removed from healthy sheep that were euthanased as part o f an 
unrelated study. The bones were stored in double-layer polyethylene wrappings at a 
temperature o f 20°C'. The graft was prepared in a similar fashion to that described in 
the previous chapter. HA was derived from 2-5m m  diameter calcium phosphate 
ceramic granules (ApaPore ApaTech Ltd), with a pore size o f 230 gm and
porosity o f 60%.
3.2b Harvesting o f sheep m esenchym al stem cells
Under general anaesthesia, an area o f  10 x 10 cm over the iliac crest o f the sheep was 
prepared by shaving and scrubbing. After aseptic preparation, a stab incision with a 
No 11 scalpel was made through the skin. A Rocket Medical biopsy needle (11 
gauge, 10cm) was introduced into the iliac crest and two 4mls aliquots o f bone 
marrow aspirated into 5ml syringes, preloaded with 1 ml heparin (1000 iu/ ml) (Fig 
3.1). The marrow aspirates were oscillated gently, transferred into sterile 10 ml 
containers and placed on ice for im m ediate transfer to the laboratory.
3.2c Purification and culture o f m esenchym al stem cells*
The M SC ’s were separated using a Ficoll-Paque® density gradient teehnique similar 
to that described for the isolation o f  M SC ’s in other species (Riekard et al., 1996). 
The initial 4mls o f bone marrow aspirate was layered gently onto 3ml Ficoll (Ficoll 
Paque PLUS, Amersham Pharm acia Biotech, UK). This layered mixture was then
Purification, culture and seeding o f  the M SC s onto the graft was carried out by M iss M. Korda (Cell 
scientist at the Institute o f  O rthopaedics, IJCL)
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centrifuged at 1510 rpm (400 f>) for 30 minutes until a straw coloured buffy layer 
formed in between the plasma and Ficoll erythrocyte residue. This huffy layer was 
recovered and washed by adding 10ml D ulbecco’s Modified Eagles Medium 
(D M EM )'. The sample was spun at 2000rpm (702 f») for lOmins to remove the 
heparin and Ficoll. The supernatant was discarded and the cell pellet re-suspended in 
12 ml DMEM. This cell suspension was then plated into T25 (25-cm^) flasks. The 
cells were m aintained at 37°C in a fully humidified atmosphere containing 95% air 
and 5% CO 2.
The primary seeded cells were allowed to adhere to the flask for 2 days before 
changing the m edium  and thereafter, the medium was changed every 3 days for 14-16 
days when colony-form ing units were visible. When culture dishes reached 
confluence (usually 2 weeks after the original plating), cells were harvested with 
0.05%  trypsin (Sigma), washed with 5mls o f PBS and re-suspended in DMEM. These 
cells were expanded for a further 5-9 days until confluent.
Cells were rem oved from the flask using trypsin digestion and centrifuged at 
2000rpm (702 g )  for 5mins to pellet the cells. The medium supernatant was discarded 
and the cell pellet re-suspended in 1ml fresh DMEM. The cells were re-plated and the 
medium changed every 3 days. Cells that had reached passage 2 to 6 were used in this 
study. A 20 pi aliquot was aspirated and counted in a haemocytometer to give the cell 
count/ml.
' Sigm a Aldrich, Poole; 4500m g/l g lu cose, L-glulam ine and sodium  pyruvate with 10% foetal ca lf  
serum,
penicillin  50 iu/ml and streptom ycin 50 pg/m l)
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Fij*ure 3.1: Bone marrow harvesting from the iliac crest 
3.2(1 Suspension seeding of M SC’s onto graft material*
M SC’s were seeded at 2x10^ cells/g onto 3.5g o f allograft or HA. All cells were 
confluent at passage 3. M SC’s were trypsinised from culture flasks and counted. 
Cells were seeded onto graft material in a universal tube with 7ml DMEM. Cells were 
attached to the graft material in the universal tube that was rotated on a TAAB rotator 
(TAAB, UK) for 2.5 hours. The cells were then transferred to a 6 well plate and were 
maintained in culture for 4 days prior to the operation.
* Purification, culture and seeding of the M SCs onto the graft was carried out by Miss M. Korda (Cell 
scientist at the Institute o f  Orthopaedics, UCL)
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3.2e Im paction of com posite j»raft
Treatment mixtures comprising o f allograft ±  MSCs and HA ± MSCs were impacted 
at 3kN to form a cylindrical pellet immediately before insertion into a metaphyseal 
defect. A quantity o f the mixture was placed within a specially designed impaction 
hammer (Fig 3.2) and impacted twenty times by a piston driven by a slap hammer. A 
standard level o f twenty impactions was applied throughout the study, as graft 
compaction has been shown to occur in the first 20 impactions and little change 
occurs in the dimensions o f the graft thereafter (Phipps et al., 2002). The resulting 
graft measured 21 x 15mm and was retained within the tube in which it had been 
impacted.
a b
II all
Figure 3.2: Impaction hammer design: (a) showing (1) impaction cylinder, (2) 1 kg 
weight, (3) stop at 2.5 cm above the weight (delivers 3kN force) and (4) site for 
impaction cylinder; (b) impaction cylinder placed in the hammer with impactions 
performed as shown
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Twelve adult skeletally mature ewes (mean body weight 70.9 ± 6.5 kg) were used in 
the study. Each animal underwent surgery to both its medial femoral condyles, thus 
twenty-four operative procedures were performed. In six animals, the treatment 
mixture com prised o f  allograft + MSCs on one femoral condyle and allograft alone 
on the contralateral femoral condyle. In the other six animals, the treatment mixture 
comprised o f  HA + MSCs on one femoral condyle and HA alone on the contralateral 
femoral condyle. In this way, each subject acted as its own control.
3.2f Surgical procedure
All surgery was conducted in com pliance with United Kingdom Home Office 
regulations. Animals were individually housed in pens, forty-eight hours prior to the 
surgery. Only fluid intake was perm itted twelve hours before the operations. 
Premedication and anaesthesia was adm inistered as described in the previous 
chapter. In the anaesthetic room, a large area over the antero-medial aspect o f each 
knee was shaved and thoroughly cleaned with Povidine solution.
The sheep were placed in the lateral position on the operating table. The medial 
femoral condyle was approached via a 4cm incision made just proximal to the knee 
joint and continued along the fem oral shaft. The incision was extended deeply 
through the subdermal fascia and m uscle until bone was reached. The soft tissues 
were retracted using self-retainers and haemostasis established. A femoral guide 
plate secured with two 2.7mm cortical screws was used to guide the insertion o f 
Tufnol tubes containing the impacted graft mixtures into the defects (Fig 3.3).
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Unicortical metaphyseal defects o f  15mm in diameter were created, with the aid o f  a 
drill centraliser, in the distal femur at the level o f  the medial condyle (Fig 3.3). At 
each site, a 5mm diameter pilot hole was drilled in the near cortex. The depth o f the 
defect was drilled to 4mm deeper (Fig 3.4) than the height o f the pellet created by 
impacting the morsellised graft material (Fig 3.4). A 15mm drill was used to enlarge 
the unicortical defect. The Tufnol tube containing the graft plug was mounted 
onto the guide plate and the plug gently introduced into the bone defect using a 
polyethylene punch (Fig 3.4). The plate and screws were removed and the soft 
tissues and skin closed in two layers with an absorbable suture.
The sheep were turned, re-draped and the operation repeated on the contralateral 
femoral condyle. Following surgery, animals were allowed immediate postoperative 
mobilisation and weight-bearing as tolerated. Antibiotic and analgesic prophylaxis 
was administered daily with subcutaneous injections o f  Baytril (Enrofloxacin 
5mg/kg; Bayer AG Leverkusen) and Finadyne (Flunixin Meglumine 2mg/45kd; 
Schering-Plough Ltd) for 3 days post-surgery. All sheep were euthanased 6 weeks 
after surgery with an overdose o f  intravenous Pentobarbitone. The femur was 
harvested through the old incision.
3.2g Defect densitometry
After removing skin and soft tissue, the limbs were fixed in 10% formaldehyde 
solution and analysed with computed tomography (model XCT 2000, Stratec 
Medizintechnik, Germany) (Fig 3.5). Transverse scans were taken using 0.2mm- 
thick contiguous slices from the middle o f  the graft. The pictures produced by the 
scanner provided bone mineral density (BMD) data in the form o f  colour transverse
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section images (Fig 3.6). Blue and black represents a BMD above 600 mg/cm^ 
whilst red and grey represents a BMD below 250 mg/cm^. Three areas on each scan 
were evaluated: (1) anterior host-graft interface; (2) posterior host-graft interface; 
and (3) middle o f the graft (Fig 3.6). BMD for each of the regions was calculated 
separately. Data from the anterior and posterior interfaces were averaged to give one 
set o f data for the Graft-Host Interface.
Figure 3.3: Formation o f a medial femoral condyle defect: (a) a drill centraliser (1) 
is placed over a femoral guide plate (2); (b) a stopper (1) is used to ensure drilling to 
a pre-determined height.
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Figure 3.4: Calculation o f depth o f femoral condyle defect to be created. The depth 
o f the defect was drilled to 4mm deeper (b) than the height o f the pellet created by 
impacting the morsellised graft material (a). The Tufnol™ tube containing the graft 
plug was introduced into the bone defect (c) using a polyethylene punch (1).
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Figure 3.5: Computed tomography machine used to measure defect densitometry.
a f  nni lo r  d ia a n M lic
1
Figure 3.6: CT Images o f Allograft (left) and HA (right). BMD was calculated for 
the 3mm wide areas marked on the right image.
3.2h Histology
Muscle and soft tissues were removed from the limbs following CT. Each bone was 
sectioned with a band saw to leave an area comprising of the femoral condyles.
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Initially the samples were fixed in formal saline' and then prepared for histology in a 
similar fashion to that described in Chapter 2.
3.2i Histom orphom etry
The slides were exam ined in three regions in the same m anner as the BMD 
estimations: (1) anterior host-graft interface; (2) posterior host-graft interface; and (3) 
middle o f the graft (Fig 3.7). Four pictures were taken at random in each region o f 
analysis (twelve pictures per slide), the area fraction o f original graft (allograft or HA) 
and new bone were m easured using the KS 300 image analysis system (Fig 3.7). The 
data is represented as percentage o f  remaining graft and percentage o f new bone 
formation. The data for the anterior and posterior interfaces were averaged to give one 
set o f data for the G raft-H ost Interface.
3.2j Statistics
Bone mineral density and histom orphom etric data were analysed using the SPSS (v 
10.1) statistics software and subjected to paired t-test. Results are shown as mean ± 
standard m ean error.
BDH  Laboratory supplies
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Figure 3.7: Histological analysis o f specimens: (a) sections stained with paragon 
and toluidine blue with areas to be analysed demarcated by the three rectangles; 
(b) x20 magnification histology sections o f HA granules (HA) and (c) allograft 
(AG) showing new bone (NB) formation and soft tissue (ST).
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3.3 Results
1 here were no postoperative complications and no evidence o f implant rejection 
in any ot the animals. One defect filled with liA  (control group) was devoid of 
all treatment material and did not exhibit any evidence o f graft incorporation.
I his was most likely because the graft had become dislodged and this specimen 
was excluded from the study. Therefore, results were analysed on 5 defects in the 
HA group and 6 defects in the stem cell seeded group.
3.3a CT densitom etry
No fractures were observed on computed tomography in any o f the samples. The 
results o f CT-derived densitom etry are summarised in Table 3.1 and Fig 3.8. At 
time zero, the BMD for HA was I 150 mg/cm^ and for allograft it was 297.6 
m g /cm \ There was no significant difference in new bone formation between the 
host-im plant interface and the middle o f the graft in either the HA or allograft 
groups. Similarly, no significant new bone formation was observed between the 
stem cell seeded graft and the control side at either region.
3.3b H istom orphom etry
The porosity o f the un-impacted graft was 60% for HA and 61% for allograft 
which, after 20 impactions with 3kN, reduced to 51% (p>0.05) and 5.7% 
(p O .O l) respectively. At time zero, 49% o f  the defect was filled with HA and 
39% with allograft. After six weeks, this remained unchanged for HA but only 
5.7% (p<0.01) o f the defect was filled with allograft signifying that most o f it 
had been resorbed (Fig. 3.9). The results o f histomorphometry are summarised in 
Table 3.2 and Fig 3.10. In both the HA and allograft groups (test and control).
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there was no significant difference in new bone formation in either the middle o f 
the graft or at the host-im plant interface (Fig 3.10). In all the groups, new bone 
formation was more prom inent at the host-graft interface compared with the 
middle o f the graft (Figs 3.11 & 3.12). With the HA group, new bone formed in 
between the HA granules as well as in some o f the pores within the granules (Fig 
3.11). In the middle o f  the implant, less new bone formation was observed and 
presence o f  fibrous tissue was evident (Fig. 3.11).
T reatment Location Test/Control
group
BMD (m g/cm  ) P value
HA
M iddle o f  graft Test 1114±25.1 >0.05
Control 1122 ± 5 1 .2
Graft-host
interface
Test 1069 ± 39.0 >(L05
Control 1123 ±39.1
Allograft
Middle o f  graft Test 243.2 ± 24.9 >0 .05
Control 259.0 ± 16.7
Graft-host
interface
Test 304.1 ± 4 1 .2 >(L05
Control 255.3 ± 22 .3
Table 3.1: Bone M ineral Density (BM D) values o r  the HA and allograft groups.
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Figure 3.8: Bone Mineral Density for (a) HA and (b) allograft groups. The 
distance between the lowest and highest horizontal lines and the edge of the 
coloured box is the bottom and top quartile range respectively; the box shows the 
interquartile range. The thick black line in the middle o f the box represents the 
median.
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Location 1 est/Control 
group
New Hone 
form ation 
('%,)
Remaining graft 
(%)
P value
Middle o f graft 1 est 5.0 ± 2.6 51.7 ± 1.9 X L 05
Control 7.3 ± 4.1 50.1 ± 2.0
(iraft-host interface Test 17.0± 5.8 50.4 ± 2.4 >(L05
<
Z Control 21.1 ± 4 .5 48.6 ± 1.7
Overall 1 est 10.87 ± 3 .6 51.1 ± 0 .7 >0 .05
Control 15.15 ± 3.7 49.35 ± 0.8
Middle o f graft Test 9.9 ± 4 .2 9.5 ±4.1 X L 05
Control 11.0 ± 2.1 5.7 ± 2 .0
2
Graft-host interface Test 25.5 ± 8.2 6.4 ±2.1 X L05
<
Control 23.7 ± 5 .4 8.9 ± 1.6
Overall Test 16.8 ± 3 .9 7.9 ± 2 .3 >& 05
Control 18.8 ± 2 .7 7.3 ± 1.3
Table 3.2: Histom orphom etric analysis: percentage new bone formation in the 
middle o f the graft and at host-im plant interface for defects filled with impacted 
HA and allograft (Control Group) and impacted stem cells seeded on HA or 
allograft scaffold (Test Group).
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Figure 3.9: Amount o f remaining scaffold at six weeks (values expressed as 
percentage).
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(b) Allograft Group
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Figure 3JO: Histomorphometric analysis: New Bone Formation in the control 
group in middle o f the graft and at the graft-host interface in the (a) HA (b) 
allograft groups and (c) comparison between the two groups.
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Figure 3.11: Histological analysis within the HA group (a) x20 
magnification (b) x50 magnification New bone (NB) bridging the gaps 
between the HA granules. Osteoblasts (OB) line the surface of newly 
formed bone. Osteocytes (OC) are trapped within the mineralised osteoid. 
Near the middle o f the graft, bone formation was present but instead was 
replaced by fibrous tissue (FT).
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à
Figure 3.12: New bone formation in impacted allograft group (a) x20 
magnification and (b) x50 magnification. (1) Osteoblasts covering the 
surface of newly formed bone (2) Primitive marrow cavity (3) 
Intramembranous ossification (4) Old allograft (5) newly formed blood 
vessels and (6) Howship’s lacunae.
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3.4 Discussion
An ovine metaphyseal femoral unieortical bone defect model was selected for 
this study. This is a suitable model for several reasons: it maximises the use o f 
animals; does not require mechanical fixation; allows evaluation o f large particle 
materials; and sheep stem cells have been shown to be a valuable model in 
determ ining the biocom patibility and osteointegration o f orthopaedic materials 
(M organ and Leopold, 2004; Griffon et al., 2001; Torricelli et al., 2000; Kon et 
al., 2000). Furthermore, the distal femur has been shown to be an ideal location 
to assess the incorporation o f  biom aterials and osteogenesis (Griffon et al., 2001; 
Lu et al., 1998). However, while simulating some o f the environmental 
characteristics encountered in revision hip arthroplasty (contact with cancellous 
bone), this model did not intend to mimic the loading conditions encountered 
clinically.
W ithin all the groups, there was more bone formed at the graft-host interface 
than in the m iddle o f  the graft. A t the graft-host interface, recruitment o f host 
osteoblasts is an expected response to injury. If  the stem cells had made a 
contribution to bone form ation, the single most important difference in the 
pattern o f new bone form ation would have been filling o f the internal macropore 
space with bone formed directly by introduced MSCs which had differentiated 
into osteoblasts. However, other studies (Kon et al., 2000) evaluating the effects 
o f autologous bone m arrow stromal cells loaded onto biomaterials have also 
shown a similar pattern o f  bone growth. Possible explanations for this include (a) 
an increased density o f  loaded cells within the peripheral regions o f the 
composite graft (b) superior survival o f the loaded cells at the graft-host
136
CHAPTER 3
interface, which are possibly vascularised earlier and more effectively than the 
middle regions and (c) stimulation o f endogenous osteoprogenitor cells, within 
the host tissues, by the implanted cells via a positive feedback mechanism.
The lack o f  contribution to bone formation by stem cells, in this study, contrasts 
with results observed by others (Kon et al., 2000) who showed that cells loaded 
onto porous HA scaffold produced a far more extensive bone formation than cell 
free implants in tibial defects in sheep at 8 weeks. However, there are several 
noticeable differences between their study and this one. Firstly, Kon et al used an 
external fixator to achieve mechanical stability and this could potentially cause 
mechanical stimulation o f  both implants and bone resected ends. Secondly, they 
used fibrin as a cell sealant, which itself has been shown to promote osteogenesis 
from the host osteoprogenitor cells (Fortunato et al., 1997). Finally, their scaffold 
consisted o f  HA cylinders and not granules, as used in this study. The 
morphology o f  the scaffold has been shown to be crucial in tissue engineering 
and is discussed in the next chapter.
Another important difference between my study and that o f  Kon et al is that I 
impacted cells whereas they used un-impacted cells. Intra-operative 
measurement o f  forces during femoral impaction allografting in revision hip 
surgery have shown a range o f  3 to 9 kN (Phipps et al., 2002) with the majority 
o f the impactions being between 3 to 6 kN. However, there is a wide variability 
in impaction forces generated by different surgeons and also by the same surgeon 
operating on different patients (Phipps et al., 2002). Therefore, a 3kN impaction 
force used in this study may not be representative o f  the average impaction force 
generated during revision hip surgery. Although, stem cells are able to survive
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the impaction process in-vitro (Korda et al., 2006), the purpose o f  this study was 
to evaluate if  a similar finding would be observed in-vivo and therefore a 
smaller impaction force o f  3kN was used.
Another important factor contributing to the lack o f  new bone formation in this 
study may be the osteogenic potential o f  the site o f  implantation. In this study, 
the samples were impacted into a site where the blood supply was good and 
where there was an abundance o f  osteoblasts and probably other stem cells from 
the host bone to support bone formation. So it may be that in both situations bone 
formation was at an optimal level and other factors prevented the stems cells 
from having a significant effect. It maybe that in a site where osteoblasts are 
reduced in number, the effect o f  stem cells would be more pronounced. 
However, this theory warrants further investigation.
One study that has shown success using stem cells loaded onto a HA/TCP 
scaffold was in a goat model (Kruyt et al., 2003). However, in this study, the 
investigators were unable to prove that the implanted cells were present in the 
bone that subsequently formed, due to the absence o f  a reliable tracing method to 
mark their cells. It is also plausible that their osteoinductive scaffold could have 
stimulated osteogenic differentiation o f  cells. Although the mechanism 
responsible for this theory remains a speculation, it is well established that 
osteogenesis occurs in well-defined cavities (Ripamonti, 1996). It is therefore 
possible that in such cavities, there occurs an accumulation o f factors that are 
fundamental for induction and/or differentiation o f the cells (Yamasaki and 
Sakai, 1992). In addition, such a microenvironment may support calcium 
phosphate break down and reprecipitation, possibly in combination with crucial
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factors. Such an induction phenomenon can be supported by the finding that 
osteogenesis inside arteriosclerotic plaques only occurs as a final stage, inside 
calcified (HA) plaques (Deneke et al., 2001).
The method used for the isolation and culture o f  human MSCs in our laboratories 
has yielded cells that have successfully been differentiated into adipocytes, 
chondrocytes and osteoblasts (Kalia et al., 2006). Furthermore, cells loaded onto 
an allograft scaffold have been shown to be capable o f  differentiating into 
osteoblasts (Rust et al., 2007). My seeding technique was validated by scanning 
electron microscopy, showing the attachment o f  the seeded cells on to allograft 
and HA granules. However, the seeding efficiency was not verified. Thus, 
although 2x10* cells were seeded onto the scaffold, there could have been a 
reduction in the number o f  cells on the graft at the time o f implantation. 
Furthermore, 2 x 1 0 *  cells per cm^ o f  scaffold is a much lower density than that 
used by others who have demonstrated success with the use o f  stem cells (Kruyt 
et al., 2003; Bruder et al., 1998). It is possible therefore that we had an 
insufficient quantity o f  stem cells in the composite grafts to enhanced bone 
formation.
Once seeded with cells, the graft was incubated for 4 days prior to implantation 
to allow the cells to lay down extracellular matrix. Recent evidence suggests that 
viable cells rather than the extracellular matrix are essential for bone formation 
(Kruyt et al., 2003) and therefore, many authors favour seeding the graft at the 
time o f  implantation (Bruder et al., 1998). However, results from other studies 
(Mendes et al., 2002) have shown that scaffolds on which cells have been seeded
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for up to 5 days before implantation, induce faster bone formation compared with 
scaffolds in which cells are seeded and implanted a few hours later.
Most studies using mesenchymal stem cells have used alkaline phosphatase 
(ALP), which is an enzyme tightly bound to the cell membrane, as a marker o f  
osteoinductive cells. A peak o f  ALP activity is found to precede the increase in 
the rate o f  mineralisation. However, as in other studies (Kon et al., 2000), we 
found that ALP activity was almost undetectable in sheep MSCs and at the time 
o f  the study there was no method to confirm the presence o f osteoinductive cells. 
Furthermore, at the time o f  this study there was no reliable tracing method to 
mark the MSCs and this posed a major difficulty in determining if  stem cells had 
contributed to new bone formation. Currently, studies are on going at our 
Institute to examine the use o f  Green Fluorescent Protein (GFP) and lacZ as 
potential markers to trace stem cells.
Inoue et al. (1997) studied the effect o f  aging on osteoblastic differentiation o f  
marrow stromal cells loaded onto porous hydroxyapatite in rats. They found 
reduced bone formation in older bone marrow cells and concluded that this may 
have been due to a lesser stromal cell population and /or the reduced potential o f  
stromal cells to differentiate down the osteogenic pathway. Nishimoto et al. 
(1985) assessed ectopic bone formation by subcutaneously implanting crude 
BMP powder in rats o f  different ages. High ALP activity appeared later in older 
rats compared with younger rats, and ALP activity was decreased in older rats. In 
this study, sheep with a variable age range were used (average age 2-4 years) and 
it is possible that this could have adversely affected the stem cell population and 
/or their differentiation capability, resulting in the results observed.
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Following implantation, the graft is incorporated in a process that is similar to 
that o f  fracture healing (Tagil, 2000) which is initiated by haematoma formation 
at the graft site. Incubation o f  endothelial cells in fracture haematoma 
supernatant has been shown to significantly inhibit the in vitro angiogenic 
parameters o f  endothelial cell proliferation and microtubule formation (Street et 
al., 2000). Furthermore, fracture haematoma potassium concentration is known 
to be cytotoxic to endothelial cells and osteoblasts (Street et al., 2000). It is 
therefore possible that the local environment within the defect proved too harsh 
for the stem cells to survive in.
Although most o f  the clinical series have evaluated the cemented impaction 
allografting technique (Mikhail et al., 1999; Meding et al., 1997; Elting et al., 
1995; Leopold et al., 1999; Gie et al., 1993), this study did not use cement 
because o f  the potential risks o f  destroying the stem cells from the heat generated 
by the cement. Defects were only covered with the vastus medialis muscle. This 
permitted the ingrowth o f  fibrous tissue especially in the allograft group. 
Presence o f  fibrous tissue has been shown to delay or impede new bone 
formation (Gosain et al., 2004) and could also have destroyed the stem cells. 
Tissue Guided Regeneration (TGR) is a technique that has been used to 
overcome this particular problem by using barrier membranes such as 
polytetrafluoroethylene (PTFE), to prevent the prolapse o f adjacent tissues into 
the defects (Gosain et al., 2004).
In this study, the animals were euthanased at 6 weeks. The majority o f  
investigators using TE constructs have evaluated their specimens after a longer
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period (Kruyt et a l ,  2003; Yoshikawa et al., 1998; Boo et al., 2002; Kadiyala et 
al., 1997; Kon et al., 2000). It can only be speculated whether more bone 
formation would have been observed if  this study was conducted over a longer 
period. However, other studies have shown more bone formation in the TE 
constructs as early as 4 weeks after implantation o f  their grafts (Bruder et al., 
1998).
The impaction forces used resulted in the graft comprising o f  HA to be more 
compacted than the allograft. In the control groups, there was no statistical 
difference in the amount o f  new bone formed by the granular porous HA or 
allograft. In both these groups, more new bone formation was detected at the 
host-implant interface than the middle o f the implant at six weeks (p < 0.05). 
These results are similar to those observed by Heekin et al. (1995) and Won et al 
(2004) who analysed autopsy retrievals o f acetabular reconstructions with 
allograft and HA respectively. In both these studies, bone penetration only 
occurred at the peripheral junction o f  the graft with cortical bone and the central 
graft had only myxofibrous tissue with no live bone, as long as 18 months 
postoperatively. The current report demonstrates that hydroxyapatite does not 
need to be mixed with allograft to induce adequate bone formation. However, the 
tendency for bone formation to occur only in restricted regions remains a concern 
because this could hinder continuous bone formation that is, for example, 
mandatory in spinal fusion. Furthermore, central defects that only provide soft 
tissue contact for morsellised allograft or HA could compromise the stability o f  
the graft.
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There was a significant difference in the rate o f  resorption between the allograft 
and HA groups at six weeks, with the allograft being almost completely resorbed 
whilst there was minimal resorption o f HA. An ideal bone graft substitute 
material from both a biological and biomechanical point o f  view is one that is 
completely replaced by new bone formation from the host. However, in order for 
the graft to maintain or increase structural properties, the graft material has to be 
replaced by bone formation. If resorption is faster than bone formation, then the 
structural integrity o f  the graft may be compromised. This study confirms 
previous reports (Hyakuna et al., 1990) that although HA is an excellent bone 
substitute, it does not replace new bone because o f  its biodegradable 
characteristics as a scaffold. In my study I showed that degradation o f  the HA 
was much slower than the allograft. Moreover, the HA became bound to the host 
bone (Jarcho et al., 1977) and remained connected to it via new bone that formed 
into the interconnected interpores (Won et al., 2004; Bolder et al., 2003). 
Resorption o f  allograft in this model allowed greater ingrowth o f  fibrous tissue. 
This could potentially compromise the stability o f  the construct. The HA was not 
resorbed after 6 weeks and hence may be more stable.
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3.5 Conclusion
Impacted hydroxyapatite (HA) induces the same amount o f  bone growth as 
impacted allograft. Although mesenchymal stem cells (MSCs) have been shown 
to survive the standard impaction forces measured at revision hip surgery in an 
in-vitro model, this study showed that the addition o f  MSCs to allograft or HA 
granules did not enhance more bone formation in-vivo. This may be because 
stem cells lose their differentiating capacity after impaction. This warrants 
further investigation and forms the basis o f  the next chapter.
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CHAPTER 4
THE EFFECT OF MESENCHYMAL STEM CELLS 
ON NEW BONE FORMATION IN IMPACTION 
GRAFTING: AN IN VIVO ECTOPIC MODEL
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4.1 Introduction
To date, many studies have been performed to optimise the isolation, expansion and 
seeding o f  mesenchymal stem cells to increase their bone-forming capacity (Bruder et 
al., 1998; Gundle et al., 1995; Dennis et al., 1992). It has been shown that combining 
MSCs with a porous ceramic scaffold is a feasible concept to generate bone 
ectopically, or in critical sized defects in rodents (Ohgushi et al., 1989; Yoshikawa et 
al., 2000; Bruder et al., 1998; Bruder et al., 1997). However, transferring this 
technology to larger animals has been challenging (Decker et al., 1979; Deleu and 
Trueta, 1965) and only a few reports have demonstrated bone formation 
orthotopically (Bruder et al., 1998; Kon et al., 2000) or ectopically in rabbits, dogs 
and goat (Anselme et al., 1999; Peter et al., 2000; Kruyt et al., 2003).
One reason that bone tissue engineering has appeared to be much more difficult in 
larger animals might be due to impaired cell survival, as the metabolic rate o f  these 
animals is lower and/or larger implants are required. In addition, experimental defects 
created in larger animals are usually bigger and this has consequences in terms o f  
vascular invasion and survival o f cells deep within the larger scaffolds. These 
potential reasons are supported by previous studies that report negligible cell survival 
and delayed revascularisation o f  bone grafts after auto-transplantation (Decker et al., 
1979; Deleu and Trueta, 1965; Nettelblad et al., 1984; Redondo et al., 1997). In 
addition, there is a lack o f  vascularisation until the first week after implantation, 
which may compromise cell survival (Decker et al., 1979; Deleu and Trueta, 1965). 
This could explain why there was no effect o f the mesenchymal cells on bone 
formation in the bone defect site reported in the previous chapter.
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Research at this institute has shown sheep MSCs are able to survive impaction forces 
up to 6 kN (Korda et al., 2006). In the previous study, a smaller impaction force o f  
3kN was used to ensure cell survival. However, it is possible that although stem cells 
survive impaction, their differentiating capacity is reduced as a result o f  the impaction 
process. This theory warrants further investigation.
In the previous study a metaphyseal femoral condyle defect model was used to 
investigate the osseoinductive capacity o f  impacted TE constructs. Although this 
model has several advantages, the environment does not simulate the conditions 
encountered clinically during a revision situation where impaction grafting would be 
used. For example, this area has a good blood supply and does not mimic the poor 
bone stock encountered in a clinical revision situation. Furthermore, within the sheep 
condyle the environment is very conducive to bone formation and any effect that the 
stem cells would have had may have been masked. To rule out osteoconduction or 
periosteal bone formation (Bruder et al., 1998; Kon et al., 2000) as confounding and 
overriding mechanisms o f  bone formation, ectopic implantation sites have been used 
successfully to investigate the bone-forming osseoinductive capacity o f  tissue- 
engineered constructs implanted in goats (Kruyt et al., 2003). To our knowledge, 
there has been no documented use o f  ectopically implanted tissue engineered 
scaffolds in sheep. An extra-skeletal model would indicate the osseoinductive nature 
o f  the combined scaffold and stem cells and has the added benefit o f  allowing the 
investigation o f  many variables in one animal.
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4.1a Hypothesis
This pilot study will explore the hypothesis that the addition o f  MSCs to allograft or 
HA granules will enhance the amount o f new bone formation when compared with 
allograft or HA granules alone in an ectopic site and that impaction grafting using 
graft and stem cells will not result in a reduction o f  bone formation.
4.1b Objectives
Ectopic bone formation will be assessed by histology and histomorphometry o f non­
decalcified sections to generate data within the graft for new bone formation and bone 
attachment to the scaffold.
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4.2 Methods
4.2a Experimental design
Two skeletally mature ewes (mean body weight 70.9 ± 3 . 5  kg) were used in this 
initial study. The purification, expansion and culture o f MSCs onto the graft material 
have been described previously. All cells were confluent at passage 3; 10x10* cells/g 
were seeded onto the scaffold. Two scaffold types, allograft and HA60/400 (HA with 
60% interconnected macroporosity and an average pore size o f 400pm) were 
investigated and divided into eight treatment units (Table 4.1). For unimpacted 
samples, sufficient scaffold was used to fill a volume o f  3cm^ and then seeded with 
the same volume o f  plasma +/- MSCs as the impacted group. One unit o f each 
treatment was transferred into a stainless steel mesh and the mesh sutured at each end. 
Each mesh sample was randomly allocated to one o f 8 implantation positions in the 
paraspinal muscle (4 sites either side o f  the spine) o f the sheep from which the MSCs 
were derived (autologous implantation).
4.2b Surgical procedure
All surgery was conducted in compliance with the 1986 Animal Scientific Procedures 
Act as regulated by the United Kingdom Home Office. Pre-operative preparation was 
similar to that described in the previous chapters. The surgical procedures were 
performed under general inhalational anaesthesia, preceded by intravenous Ketamine 
and/or Midazolam (Roche Products, UK) and maintained by inhalation o f Halothane 
(Meriel Animal Health Ltd) as described previously.
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Sample composition Sample type
Impacted group
Allograft alone Control
Allograft with MSCs Test
HA Control
HA with MSCs Test
Unimpacted
group
Allograft alone Control
Allograft with MSCs Test
HA Control
HA with MSCs Test
Table 4.1: Composition o f  the eight treatment units used in this study
In the anaesthetic room, the lumbar area was shaved and thoroughly cleaned with 
Povidine solution. The sheep was placed in a prone position on the operating table 
and four skin incisions (approximately 3cm in length) were made over the body o f  the 
paraspinalis muscle (Fig 4.1). The muscle épimysium was exposed and divided. 
Using blunt dissection, an intramuscular pocket was created, which was filled with 
one o f  the four treatment units. The épimysium was closed with 2/0 non-absorbable 
ethylon suture to facilitate implant localisation at explantation. The skin was closed in 
2 layers with an absorbable vicryl suture. Post-operative care was similar to that 
described previously and included prophylactic antibiotics and analgesia. There were 
no post-operative complications and no evidence o f implant rejection. By the second 
postoperative day, the sheep were moving around normally. Both sheep were 
euthanased 12 weeks after surgery with an overdose o f  intravenous Pentobarbitone.
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Figure 4.1: Ectopic implantation o f graft in sheep. Four incisions were made to 
access both the paraspinalis muscle groups.
4.2c Histology and histomorphometry
At explantation, the units were localised, the surrounding muscle tissue excised, and 
the constructs placed in 10% buffered formal saline. The samples were prepared for 
histology as described in the previous chapters. The sections were examined using a 
fluorescence/light microscope with a double filter block. Digital photographs o f the 
whole sample were taken using a low power x40 magnification. Area of new bone 
formation and remaining scaffold (allograft or HA) were quantified using the Image 
Tool 3.0 software (UTHSCSA, Texas, USA). The percentage of new bone formation 
was expressed as the amount o f new bone divided by the total area available for new 
bone generation within the area enclosed by the mesh. Statistical analysis was not 
performed due to small sample number.
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4.3 Results
4.3a Allograft group
In both the impacted and unimpacted groups, there was more new bone formation 
when allograft was seeded with mesenchymal stem cells compared with allograft 
alone (Fig 4. 2, Table 4.2). In the impacted samples there appeared to be more bone 
formation than in the unimpacted samples. New bone formed on the surface and in 
the pores o f partially degraded allograft. In some cases, new bone bridged between 
separate segments o f allograft. There were also areas o f unmineralised osteoid and 
ongoing ossification, not yet matured into new bone (Figs 4.3 & 4.4).
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Figure 4.2; Graph showing percentage new bone in different allograft groups.
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New bone formation (%)
Sample 1 2 Mean of two samples
Impacted allograft 
(control) 0 0.58 0.29
Impacted allograft 
with MSC’s (test) 1.22 3.22 2.22
Unimpacted allograft 
(control) 0 0 0
Unimpacted allograft 
with MSC’s (test) 0 0.21 0.105
Table 4.2: Percentage new bone formation in impacted and unimpacted allograft 
samples
Figure 4.3: New bone (a) forming on allograft (c) with areas of ongoing ossification 
(b) (x 40 magnification).
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Figure 4.4: High magnification image (xlOO) o f new bone formation within pores of 
allograft (a). Osteoblasts (b) line the surface of newly formed bone. Angiogenesis (c) 
is evident as is new bone in areas excavated by osteoclasts (d).
4.3b Hydroxyapatite group
There was no new bone formation in either the impacted or unimpacted 
hydroxyapatite groups. Although there was evidence o f angiogenesis, pores were 
filled with fibrous tissue, with no evidence of any unmineralised osteoid (Fig 4.5).
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#
Figure 4.5: Impacted hydroxyapatite (a) demonstrating evidence of angiogenesis (b) 
and fibrous infiltration into pores (c) (x40 magnification).
4.3c Unresorbed scaffold
At 12 weeks, there was less allograft remaining than hydroxyapatite. The amount of 
allograft reduced from 39% at time zero to between 6 and 21 percent in both the 
impacted and unimpacted groups (Table 4.3, Fig 4.6). The amount of HA at time zero 
was 49% and this remained unchanged in the impacted group and reduced minimally 
in the unimpacted group (Table 4.3, Fig 4.6).
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Remaining Scaffold 
(% )
Impacted
Group
Allograft without MSCs 17
with MSCs 21
HA without MSCs 49
with MSCs 49
linimpacted
Group
Allograft without MSCs 17
with MSCs 6
HA without MSCs 30
with MSCs 37
Table 4.3: Percentage remaining seal fold in the allograft and HA groups.
Percentage of scaffold remaining at eight weeks
60
50
sP 40
30
0)O)
(0 A->c  0)
e
s .  20
10
2 3
sample num ber
■  impacted allograft”
■  unimpacted allograft
□  impacted HA60
□  unimpacted HA60
Figure 4.6: Bar Graph demonstrating mean remaining scaffold as percentage field 
analysed at 8 weeks
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4.4 Discussion
There are no animals with the same anatomical, biochemical, physiological and 
biological characteristics as those o f human beings. Non-human primates are 
considered to be the closest to humans in terms o f both their biomechanics and 
physiology, but on ethical grounds they are rarely used in research in the modem era. 
For similar reasons, orthopaedic research using canine models and other companion 
animals have also has declined in recent years. For this reason and given the fact that 
bone mineral composition and bone healing characteristics in sheep are similar to that 
o f humans (M artini et al., 2001), the ovine model has become increasingly popular in 
orthopaedic research. Furthermore, sheep are readily available and easy to maintain. 
Although sheep stem cells have been shown to be a valuable model in determining 
the biocompatibility and osteointegration o f orthopaedic materials (Morgan et al., 
2004; Griffon et al., 2001; Torricelli et al., 2000; Kon et al., 2000), some studies 
(Decker et al., 1979; Deleu and Trueta, 1965) and indeed our previous study have 
raised concerns that transforming this knowledge to larger animals may prove to be 
challenging. However, in this initial small study, it has been demonstrated that 
osteogenicity o f tissue-engineered constructs can be successfully investigated using 
ectopic implantation sites in sheep. Extra-skeletal experiments have the added benefit 
o f allowing the investigation o f many variables in one animal whilst eliminating the 
influence o f host bone.
From the current study, it has been shown that the presence o f living, culture- 
expanded mesenchymal cells combined with an allograft scaffold induces more 
ectopic bone formation than allograft alone. Conversely, a porous calcium phosphate 
scaffold either alone or combined with mesenchymal cells failed to produce any new
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bone ectopically in sheep. The low values o f bone formation observed, even in the 
best samples, are equivalent to amounts seen in other publications (Kruyt et al., 
2003). These results have to be interpreted with some caution due to the small sample 
number.
Our results are in direct contrast to those observed by another study (Kruyt et al., 
2003), which showed that a composite graft consisting o f a porous HA scaffold 
combined with osteoprogenitor cells is a prerequisite for in vivo ectopic bone 
formation in larger animals. However, in that study, the assumption that viable cells 
were responsible for bone formation contrasts with their finding o f reduced bone 
formation at the scaffold periphery. Cell survival in this area can be expected to be 
much higher as a result o f revascularisation and nutrient diffusion (Pelissier et al., 
2003). Furthermore, the investigators o f the study were unable to prove that the 
implanted cells were present in the bone that subsequently formed due to the absence 
o f a reliable tracing method to mark their cells. One observation from the present 
study which does correlate with that reported by Kruyt et al., (2003) is that the HA 
scaffold on its own does not induce bone formation ectopically in the larger animal 
model after a 12 week time period.
An important morphological feature o f the scaffold, in in-vivo bone formation by a 
tissue engineering approach, is the particle size (Mankani et al., 2001). Calcium 
phosphate particles composed o f HA and tricalcium phosphate, with a diameter o f 0.1 
to 0.25 mm, have demonstrated the greatest bone formation at 4 or 10 weeks when 
combined with human bone marrow stromal cells and implanted ectopically in nude 
mice. In contrast, larger (or smaller) particles were associated with less extensive
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bone formation. Other authors (Yuan et al., 2002; Fischer et al., 2003) have reported 
that cells grown on macroporous calcium phosphates devoid o f microporosity were 
unable to produce large amounts o f bone in vivo. This has been attributed to the fact 
that large particles probably create a different macroporosity in the tissue-engineered 
construct, which could be unfavourable for bone formation. The macroporosity in our 
samples may have also affected angiogenesis or the speed o f blood vessel infiltration 
in the implanted mass and therefore inhibited survival o f the implanted cells and thus 
osteogenesis occurred within the 2-5mm particles. The presence o f bone marrow 
formation around the microporous particles observed by others (Fischer et al., 2003) 
may be related to enhanced osteogenesis followed by remodelling and resulting bone 
marrow formation.
Previous research at our laboratory has shown sheep MSCs are able to survive 
impaction forces up to 6 kN (Korda et al., 2006). In this and the previous study, a 
smaller impaction force o f  3kN was used to ensure cell survival. One concern that 
was raised from the last study was that although stem cells survive impaction, their 
differentiating capacity may be reduced as a result o f the impaction process. This 
theory warrants further investigation. This study has shown that impaction did not 
have an adverse effect on new bone formation in the allograft group. Moreover, an 
impacted tissue-engineered allograft construct demonstrated an increase in new bone 
formation compared with the unimpacted group. It can be reasonable to assume that 
with the use o f  autologous plasma as a seeding medium, MSCs survive impaction 
forces when transplanted in vivo, and continue to differentiate into osteoblasts and 
stimulate new bone formation.
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Conclusion
The osteogenicity o f  tissue-engineered constructs can be successfully investigated 
using ectopic implantation sites in sheep. Impacted tissue-engineered allograft 
constructs demonstrated an increase in new bone formation compared with the 
unimpacted group. Conversely, an impacted and un-impacted porous calcium 
phosphate scaffold, either alone or combined with mesenchymal cells, failed to 
produce any new bone ectopically in sheep. These results have to be interpreted with 
caution due to the small sample number.
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CHAPTER 5 
THE EFFECT OF SCAFFOLD ARCHITECTURE ON 
OSSEOINDUCTION BY MESENCHYMAL STEM CELLS
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5.1 Introduction
There is no doubt that a bonding osteogenesis process, in which osteogenic precursor 
cells become attached to the biomaterial implant surface, aggregate, proliferate, 
differentiate, produce bone matrix and ossify, has been observed in calcium 
phosphate biomaterials (Dekker et al., 1998). However, in the study by Kruyt et al 
(2003) significantly less bone was formed when cells were combined with HA60/400 
(HA with 60% interconnected macroporosity and an average pore size o f 400pm), as 
used in the pilot study in Chapter 4, than with HA70/800 (HA with 70% 
interconnected m acroporosity and an average pore size o f 800pm). The authors could 
not provide a satisfactory explanation to account for this difference. In a mice ectopic 
model, different apatite-containing scaffolds o f similar morphology and porosity 
demonstrated marked differences in their ability to support osteoinduction by 
implanted human MSCs (Harris and Cooper, 2004). It may be that the induction o f 
human MSCs along the osteoblastic lineage may be dependent, in part, on the local 
m icroenvironment established by the scaffold chemistry and interactions with the host 
(Harris and Cooper, 2004). From the above studies it appears that the architecture o f 
the scaffold influences the proliferation and differentiation o f stem cells and could 
account for our observed differences in new bone formation. Although some 
investigators (M endes et al., 2003) have demonstrated extensive osteogenesis using 
stem cells loaded onto porous HA granules, the majority o f studies have assessed TE 
constructs with MSCs seeded onto blocks o f porous ceramic bone substitutes (Bruder 
et al., 1998; Kon et al., 2000; Kruyt et al., 2003). In fact, some authors advocate that 
bone grows in porous hydroxyapatite only if  constructed in block forms and fails to 
grow in identical porous hydroxyapatite in granular form (Ripamonti, 1996; 
Ripamonti et al., 1993; Ripamonti, 1991). In addition, experiments in rodents have
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shown that even when granular hydroxyapatite has been pre-treated with BMPs, bone 
does not form (Ripamonti, 1992). Similar results have also been observed in biopsies 
obtained after maxillo-facial augmentation in humans (Hjorting-Hansen et al., 1990). 
One reason for the observed lack o f osteogenesis could be due to micromotion 
between the individual granules and the adjacent bone interface. Micromotion has 
been shown to inhibit bone growth into porous biomaterials leading to fibrous union 
(Cameron et al., 1973).
In the pilot study described in Chapter 4, in both the impacted and unimpacted groups 
there was more new bone formation when allograft was seeded with mesenchymal 
stem cells compared with allograft alone. However, the low values o f bone formation 
observed in the study is equivalent to amounts observed by other investigators (Kon 
et al., 2000; Kruyt et al., 2003). A possible reason for this could be that although stem 
cells survive the impaction, their differentiating capacity may be reduced as a result 
o f the impaction process. One approach to address this theory would be to investigate 
the bone-forming capacity o f osteoblastic cells and compare it with undifferentiated 
mesenchymal stem cells. Techniques for directing the commitment o f MSCs into 
bone cell lineage to produce osteoblastic like cells (OBLC) which differentiate into 
osteoblasts, thus resulting in new bone formation, have been successfully developed 
(Jaiswal et al., 1997; Haynesworth et al., 1992) and reproduced in our laboratories 
(Kalia et al., 2006).
The differentiation o f stem cells can be divided into three stages: (i) a proliferative 
phase, (ii) the period o f matrix deposition and (iii) the mineralisation phase (Duplomb 
et al., 2007). Zur Nieden et al (2003) studied the expression pattern o f osteoblastic
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markers and showed that there is an increase in alkaline phosphatase (ALP) activity 
during the matrix deposition stage and a maximal expression o f osteocalcin, an 
osteoblast-associated matrix gene, at the start o f the mineralisation phase. In addition, 
the capacity o f osteoblasts to mineralise in vitro  can be visualised by von Kossa or 
Alizarin red staining (Jaiswal et al., 1997; Duplomb et al., 2007).
The study in Chapter 2 has demonstrated that the amalgamation o f HA with allograft 
in impaction grafting presents a number o f potential advantages. To our knowledge, 
there have been no previous studies to assess the suitability o f a mixed allograft / HA 
scaffold for the delivery o f mesenchymal stem cells. The previous study has 
demonstrated that the osteogenicity o f tissue-engineered constructs can be 
successfully investigated using an ovine extra-skeletal model.
5.1a Hypothesis
This study will explore the hypothesis that in an ectopic sheep model (a) impacted 
allograft seeded with M SCs or osteoblast like cells (OBLCs) will produce more new 
bone than impacted allograft only; (b) impacted HA / allograft mix (50:50) seeded 
with MSCs or OBLCs will produce more new bone than impacted HA / allograft only 
and (c) MSCs seeded onto an HA block will produce more new bone than an HA 
block alone.
5.1b Objectives
Ectopic bone formation will be assessed by histology and histomorphometry o f non- 
decalcified sections.
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5.2 Methods
5.2a Differentiation o f stem ceils for osteogenesis
The purification, culture and expansion o f MSCs have been described in the previous 
chapters. During passage 2, MSCs were cultured in an osteogenic medium (DMEM 
supplemented with lOmM p-glycerophosphate, 0.05mM ascorbic acid, and lOOnM 
dexamethasone) for a total o f 14-21 days to produce osteoblastic like cells (OBLC). 
This differentiation was confirmed by an increase in ALP activity of the cells, 
expression o f osteocalcin and positive staining with the von Kossa method.
5.2b Cell Proliferation Assay
To determine seeding efficiency and cell increase after culturing in the osteogenic 
medium, the DNA content the cell layer was measured using the fluorescent dye 
Hoescht 33342 (Sigma, B2261, U.K.). This method is based on the observation that 
when the Hoescht dye binds to DNA it becomes fluorescent. The amount o f 
fluorescence is proportional to the amount o f dye bound and thus, to the amount o f 
DNA (number o f  cells) present in the sample. In brief, each well received lOOpl o f 
5 ng/ml Hoechst 33342 in phosphate-buffered saline (PBS) and the plate was 
incubated at 37 °C for 20 min. Fluorescence was measured using a fluorescence 
reader for microplates (Ascent, Labsystems, UK) at 350excitation and 450nm 
emission wavelength. Absorbance values were converted into absolute cell numbers 
based on established standard curves.
5.2c Alkaline Phosphatase Assay
Alkaline Phosphatase (ALP) enzyme activity o f the cell layer was measured in 
triplicate cultures by rinsing twice with Tyrode’s balanced salt solution, and then
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incubating the cells with 5mM p-nitrophenyl phosphate (Randox Laboratories Ltd, 
U.K.) in 50mM glycine, ImM  MgC12, pH 10.5, at 37°C for 5 to 20 minutes. ALP 
activity was calculated after measuring the absorbance o f p-nitrophenol product 
formed at 405 nm on a microplate reader (Cobas Bio, Roche, UK).
5.2d Von Kossa Staining
Cells cultured in osteogenic medium were stained for mineral by the von Kossa 
method (Jaiswal et al., 1997). Briefly, fetal calf serum was serially diluted out o f the 
medium by exchanging 80% o f the medium several times with serum-free medium. 
The cells were fixed in 5% formaldehyde and then washed several times with PBS to 
remove any remaining serum. The fixed cells were incubated in 100% ethanol at 4°C 
for about lOmins. The ethanol was then removed and the fixed cells were incubated 
in 0.5ml 5% silver nitrate for lOmins under UV light at 254nm. The cells were then 
rinsed 2-3 times in distilled water, incubated in 5% sodium thiosulphate for 5mins 
and then rinsed with water. Only cells receiving osteoblast medium stained positive 
and turned dark.
5.2e Expression o f Osteocalcin
Osteocalcin expression was measured by ELISA (Intact Human Osteocalcin K BIA 
kit, catalog number BT-460, Biomedical Technologies, Inc., Stoughton, Me.). Media 
obtained from osteoblasts was examined for the presence o f secreted osteocalcin. 
Briefly, conditioned medium (2 ml o f medium from 40,000 cells after 72 hours) was 
collected and 20 pi o f each medium was used for the assay.
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5.2f Experimental design
Six skeletally mature ewes (mean body weight 70.9 ± 3 .5  kg) were used, for which 
approval was given by the local ethics committee. The study was divided into eight 
treatment groups (Table 5.1). Allograft was prepared and stored as described in 
Chapter 2. ApaPore 60, 2-5mm diameter, was used as HA granules whilst the 10mm 
granules were used as blocks. The allograft and HA samples were sterilised by 
gamma irradiation as described previously. M SC’s and OBLCs were seeded at 
10x10^ cells/g onto the scaffold. One unit o f each treatment group was randomly 
allocated to one o f four implantation positions in the paraspinal muscles o f the sheep 
from which the MSCs were derived (autologus implantation). The surgical procedure 
was similar to that described in the initial study. All the animals were euthanased 12 
weeks after surgery with an overdose o f intravenous Pentobarbitone.
5.2g Histology and histom orphometry
After explantation with the associated surrounding muscle, the implants were 
investigated for ectopic bone formation by histology and histomorphometry o f non­
decalcified sections. The samples were prepared for histology as described in the 
previous chapters. The sections were examined using a fluorescence/light microscope 
with a double filter block. Digital photographs through the entire area o f the sample 
were taken using a low power x40 magnification. Area o f new bone formation and 
remaining scaffold were quantified using the Image Tool 3.0 software (UTHSCSA, 
Texas, USA). The percentage o f new bone formation was expressed as the amount of 
new bone over total area available for new bone generation. New bone in contact 
with the scaffold (allograft or HA) was determined as a percentage by defining
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whether bone or fibrous tissue was in contact with the edge o f the scaffold where it 
intersected with lines on an overlay grid pattern o f 500pm.
Sample composition Sample type
Impacted group
allograft alone Control
allograft with MSCs Test
allograft with OBLCs Test
allograft / HA (50:50) mix Control
allograft / HA (50:50) mix with MSCs Test
allograft / HA (50:50) mix with OBLCs Test
Unimpacted
group
HA block Control
HA block with MSCs Test
Table 5.1: Composition o f the eight treatment groups used in this study 
5.2h Statistical Analysis
Statistical analysis was carried out using the SPSS (v lO .l) statistical software. A 
multivariate study o f  variance was used to analyse the difference between the groups. 
I f  a significant difference was observed (p < 0.05), post hoc analysis was used to 
identify the differences between individual groups.
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5.3 Results
5.3a Allograft group
There was no statistical difference in new bone formation amongst the three different 
groups, but there was a trend towards an observed mean increase in new bone formed 
when allograft seeded with MSCs was compared with allograft alone or allograft 
seeded with OBLCs (Fig 5.1).
12.00 
c 10.00
E 
Î
C  
0) o>
2 c0
e 0)
Q.
c
1 0.00 
- 2.00
8.00
6.00
4 .0 0
2.00
Allograft Control Allograft MSC 
G rou p
Allograft OBLC
Figure 5.1: New bone formation in the allograft group (mean ± S.D.).
New bone formed bridges between individual pieces o f allograft, with osteocytes and 
lacunae being clearly visible (Figs 5.2 & 5.3). New bone was differentiated from 
allograft as it stained vividly red, whereas allograft stained less intensely. Surfaces of 
new bone were covered in a layer of osteoblasts and surrounded by unmineralised 
osteoid. Osteoclasts demonstrated active areas of resorption (Figure 5.3). At time 
zero, 39% o f the defect was filled with allograft, but at twelve weeks the majority of 
scaffold had been resorbed in all three groups.
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Figure 5.2: Histological analysis of MSC seeded allograft (x40 power). Areas of 
allograft (a) bridged by new bone (b) with areas of ossification (c)
Figure 5.3: Histological analysis o f MSC seeded allograft (xlOO power). Allograft 
(a) with new bone forming within pores (b) with osteocytes (c) and osteoblasts (d) 
being clearly visible
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5.3b A llograftrHA m ixture (50:50)
As with the allograft group, there was no statistical difference in new bone formation 
amongst the different groups, but there was an observed mean increase in new bone 
formed when the graft was seeded with MSCs compared with the graft alone or graft 
seeded with OBLCs (Fig 5.4). New bone was demonstrated in the pores of HA (Fig 
5.5) and occasionally bridged granules, but minimal new bone was seen around the 
surfaces o f the HA granules. At time zero, 48% of the defect was filled with scaffold, 
of which 41% was allograft and 59% HA. At twelve weeks, most of the allograft had 
been resorbed, whilst the majority of the HA remained unresorbed.
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Figure 5.4: New bone formation in the allograft:HA (50:50) group (mean ± SD).
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Figure 5.5: Histological analysis of MSC seeded on Allograft: HA mixture (xlOO 
power). HA (a) with evidence of new bone formation within pores (b). Osteocytes 
and new blood vessels (c) can be seen within the new bone.
5.3c HA blocks
There was no statistical difference in new bone formation amongst the HA block 
groups, but there was an observed mean increase in new bone formed when the HA 
block was seeded with MSCs compared with the HA block alone (Fig 5.6). At time 
zero, 52% o f the defects were filled with allograft and this remained unchanged at 12 
weeks.
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Figure 5.6: New bone formation in HA blocks (mean ± S.D.)
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5.4 Discussion
I his study confirms and validates the results o f the preceding two experiments that 
stem cells survive the impaction process without any apparent adverse effect on their 
differentiating capacity. It should be noted that any results from this study should be 
interpreted with caution due to the small sample size. As in the study described in 
Chapter 4, eells combined with an allograft seaffold indueed more ectopic bone 
formation than allograft alone. Although this increase in bone formation was not 
statistieally signifieant, retrospeetive power analysis revealed it would require twelve 
animals within the study to demonstrate a differenee with a 95% eonfidenee interval. 
In the earlier study, a porous ealcium phosphate scaffold combined with MSCs failed 
to produce any bone eetopieally, but this experiment has shown that cells loaded onto 
a 50:50 mixture o f allograft and HA induces the same amount o f new bone formation, 
as with cells seeded on an allograft scaffold alone. The use o f an amalgamated 
seaffold has the benefit o f eombining the osteoinduetivity o f allograft with the 
structural stability o f hydroxyapatite. It may be possible to use greater amounts o f HA 
in a mixed scaffold without altering the functional capacity o f stem cells, thus 
redueing the amount o f allograft used and alleviating the problems associated with its 
use. More new bone formation was noted in the HA block group seeded with MSCs 
eompared with the other groups. This eould be because new bone was measured over 
the entire area o f the graft and this probably naturally skews the results in favor o f the 
block group as there was more scaffold per unit volume.
The addition o f Osteogenic Supplements (lOOnM p-glycerophosphate, 0.05mM 
ascorbic acid and lOnM dexamethasone) to MSCs is a reliable and well established 
teehnique for inducing rapid osteogenesis (Jaiswal et al., 1997; Haynesworth et al..
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1992). Furthermore, the expression o f alkaline phosphatase provides a reliable tracing 
method to mark mesenchymal stem cells. It is therefore plausible to assume that 
MSCs cultured in such a medium would differentiate down the osteoblastic lineage. 
However, it could be speculated that MSCs cultured in an osteogenic medium may 
become more fragile and are unable to withstand the forces o f impaction. This would 
account for the observed lack o f new bone formation, in this study, with the use of a 
TE construct with OBLCs.
The majority o f studies investigating osteogenesis using stem cells have assessed TE 
constructs with cells loaded onto blocks o f HA (Bruder et al., 1998; Kon et al., 2000; 
Kruyt et al., 2003) because o f concerns that bone fails to grow in porous 
hydroxyapatite in granular form (Ripamonti, 1996; Ripamonti et al., 1993; 
Ripamonti, 1991). The initial study in Chapter 4 failed to show new bone formation 
using cells loaded onto porous granular HA, but the current study has demonstrated 
observable osteogenesis when stem cells are seeded onto blocks o f HA. This has a 
major clinical implication as most o f the commercially available HA is produced in 
granular form. Furthermore, the impaction technique can not be used with blocks of 
hydroxyapatite.
175
CHAPTER 5
5.5 Conclusion
The addition o f MSCs to allograft or a 50:50 mixture o f Allograft:HA by impaction 
grafting enhances the amount o f new bone formation when compared with 
unimpaeted constructs. There is an observed lack o f new bone formation with the use 
o f a TE construct with differentiated osteoblastic like cells. The use o f a calcium 
phosphate scaffold, either alone or combined with mesenchymal cells, induces bone 
growth only when it is constructed in block form and not in identical porous 
hydroxyapatite in granular form. This has major clinical implications as most o f the 
commercially available HA is produced in granular form and impaction grafting can 
not be used with blocks o f hydroxyapatite.
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Revision total hip arthroplasty in the presence o f extensive femoral bone loss poses a 
considerable challenge to the orthopaedic surgeon and probably accounts for the 
inferior results observed compared with the primary procedure. For this reason bone 
grafts and bone graft substitutes are increasingly being used to replenish the bone loss 
that occurs with loosening. One method that has been successfully used to treat 
cavitary defects, in the proximal femur prior to the insertion o f a revision femoral 
prosthesis, has been the use o f impaction allografting, whereby morsellised 
cancellous allograft is impacted into defects to provide immediate mechanical 
function. W hilst in structural grafts, bone ingrowth does not usually exceed 2 to 
3mm, in impacted morsellised allografts there is greater bone integration.
Impaction allografting is the only technique, to date, that has been shown to reverse 
the loss o f bone stock caused by osteolysis. However, when evaluating long-term 
outcome studies on impaction grafting there is a wide variation in results, some as 
high as 100% survival at 10 years (Schreurs et al., 2005), others as low as 28% 
survival at 15 years (Jeffery et al., 2003). There are many factors responsible for this 
variation. Firstly, the degree o f osteolysis varies considerably amongst published 
reports. In some series, only cases with severe advanced bone loss have been included 
(M asterson et al., 1997; M eding et al., 1997; Leopold et al., 1999), whilst in other 
studies cases with such severe bone deficiencies have specifically been excluded (Gie 
et al., 1993; Ling, 1997). In some studies, the degree o f bone loss has not been 
defined at all (Eldridge et al., 1997). Secondly, it is well understood that the success 
o f impaction grafting depends upon achieving adequate initial stability followed by a 
biological response o f graft incorporation and remodelling. Surgeons have tried to 
manipulate the graft characteristics to improve one or both o f these factors. The ideal 
graft has not yet been defined. Fresh-frozen femoral heads are the most frequently
178
DISCUSSION
used, but concern remains over the potential for transmission o f disease and for this 
reason the use o f processed bone (freeze dried or irradiated bone) is attracting some 
attention. However, clinical studies using processed bone have shown inconsistent 
results and currently a review to compare the clinical effectiveness o f processed bone 
against fresh frozen bone is being conducted. The ideal size o f bone chips for the 
acetabulum has been well defined but evidence on the femoral side is less certain. 
W ashing the graft has been shown to be beneficial but the most efficient method has 
not been established. Further work is needed to define the most appropriate 
production and processing techniques o f the graft in order to generate a mechanically 
stable construct conducive to biological incorporation and remodelling. Thirdly, there 
are a vast num ber o f  confounding variables in the published reports that again limit 
valid comparisons. For example, clinical series have differed with respect to stem 
geometry, cement type, surgical approach and post-operative care o f patients 
(Leopold and Rosenberg, 2000; de Roeck and Drabu, 2001). Finally, methods o f 
patient analysis, including clinical and radiographic assessment and follow-up 
duration, have differed m arkedly among published reports (Leopold and Rosenberg, 
2000).
Despite these variations, numerous studies have shown excellent clinical, radiological 
and histological results, demonstrating that impaction grafting with allograft can 
reverse loss o f bone stock, with bone graft being replaced by new bone in both 
humans and in animal models (Toms et al., 2004). The purpose o f this research was 
to investigate whether the addition o f bone graft substitutes with allograft induces 
similar patterns o f bone formation as allograft alone. The concept of adding 
biomaterial to bone allograft is attractive because it reduces dependency on donor 
supply, minimises the complications associated with the use o f bone grafts and raises
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the possibility o f improving the biomechanics o f the graft. Furthermore, the use o f an 
amalgamated graft has the benefit o f combining the osteoinductivity o f allograft with 
the structural stability o f biomaterials. Besides an improvement o f biomechanical 
properties, expansion or replacement o f allograft with synthetic agents would have 
biological and economical advantages. Indeed, one o f the current limitations of 
impaction grafting is that it relies on the use o f allogenic bone. Substituting bone with 
synthetic granules would address the concerns over transmission o f pathogens and 
shortage o f supply.
ApaPore 60 is a porous hydroxyapatite that has been chemically and structurally 
modified to optimise host bone ingrowth in impaction whilst maintaining structural 
integrity. It has high levels o f interconnectivity between micro and macropores. This 
network allows rapid bone ingrowth, promotes revascularisation, which is essential to 
healthy bone, enhances long-term graft stability and provides a continuous host 
bone/graft composite. Besides an improvement o f biomechanical properties 
(Buckland T and Lawes P., 2002), expansion o f allograft with ApaPore 60 would 
have biological and economical advantages. Furthermore, augmenting bone graft with 
ApaPore 60 would reduce the risk o f transmission o f pathogens and address the 
shortage with the supply o f allograft (Galea et al., 1998). This thesis investigated if 
femoral impaction grafting using bone graft substitutes would yield similar results to 
that observed with allogenic bone.
In Chapter 2, I examined whether the use o f ApaPore in various combinations with 
allograft would be biologically effective and functionally stable using a cemented 
impaction grafting technique in an ovine hemiarthroplasty model. The different
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treatment groups were compared by measuring the ground reaction forces (GRF) 
passing through both the operated and non-operated hind limbs pre-operatively and at 
8, 16 and 24 weeks post surgery. GRF results are a measure o f implant function and 
how well the animal uses its operated limb and a persistent reduction in function can 
be evidence o f implant loosening. Furthermore, a failure to regain function after 
surgery implies that the loads passing through the implant and the associated 
micromotion may not be representative o f a normal healing process, which gives 
anomalous results in terms o f bone ingrowth. In addition to GRF, bone formation 
rates within each o f the experimental groups were also measured. This allowed 
quantification o f the rate o f new bone formation within each o f the groups, thus 
permitting comparison o f the osteogenic potential o f the different groups.
Results from this study demonstrated a successful fixation o f the femoral stem six 
months post surgery using impaction grafting, irrespective o f the graft combinations. 
All hips maintained functional stability when higher amounts o f HA mixture was 
used, with no significant differences identified between experimental groups when 
limb function was assessed and compared. The osseoconductive properties o f 
ApaPore were confirmed by histological and backscattered SEM analysis, which 
demonstrated a remodelled endosteal surface with abundant bone growth in direct 
contact, within and around ApaPore granules, forming a network o f mature lamellar 
bone adjacent to the implant and within the original medullary cavity. Significantly 
increased bone area was measured in Groups 1 (50:50) and 3 (90:10) compared with 
Groups 2 (70:30) and 4 (80:10:10), but there was no significant difference between 
groups 1 and 3.
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A study by Buckland & Lawes (2004) comparing the use of allograft alone with 
50:50:allograft in impaction grafting demonstrated that the 50:50 group had 50% 
greater mechanical stability, 50% decrease in subsidence and a significant reduction 
in the variability o f the mechanieal properties o f the graft material. My study has 
shown that successful fixation can be achieved with up to 90% ApaPore. It is 
doubtful whether the allograft in the 90:10 graft mixture contributed to the stability o f 
the graft, but this theory remains unproven. Other studies have shown that due to the 
poor structural integrity o f hydroxyapatite and inferior mechanical properties in 
eomparison to bone graft, impaction grafting with pure HA is not possible and 
amalgamation with allograft is necessary (Verdonschot et al., 2001; Silva et al., 
2005). Based on these assumptions, my study did not examine the osteogenic 
potential o f 100% ApaPore, but given the eneouraging results observed with a 90:10 
HA:allograft mixture, impaction grafting using pure HA granules can be investigated. 
This has important clinical implications as hydroxyapatite is readily available, easy to 
use in surgery and is not associated with the adverse effects encountered with 
allografts.
Actifuse is a phase-pure 80% porous calcium phosphate material in which the 
phosphate groups have been selectively replaced with silicate ions. Studies have 
shown that silicon is a significant dietary trace element for healthy bone formation 
(Carlisle, 1981; Schwarz and Milne, 1972) and stimulates osteoblastic differentiation 
to form new bone (Patel et al., 2002). Moreover, the surface chemistry o f Aetiftise has 
been shown to enhanee adsorption and activation o f the proteins involved in 
osteogenesis, leading to much more rapid and better quality bone formation than with 
hydroxyapatite alone (Hing et al., 2006). In my study, however, the impaetion process
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was shown to alter the mechanical and biological properties o f Actifuse differently to 
that o f phase pure hydroxyapatite. It may be that the Actifuse particles fracture under 
impaction or deform elastically and are damaged to a significant level. In-vitro 
studies evaluating the time dependent mechanical properties o f Actifuse would 
provide answers to this question. Furthermore, Actifuse is currently only supplied 
with 80% porosity, however bone substitutes with large porosity have been shown to 
deform more easily during impaction grafting than less porous biomaterials 
(Verdonschot et al., 2001). Although the exact porosity o f biomaterials that mimic the 
biomechanical properties o f bone graft is not known, studies have shown that a high 
porosity is a desirable feature o f synthetic bone substitutes as it enhances 
neovascularisation, which is essential for osseointegration (Virolainen et al., 1997). 
For this reason, most biomaterials are produced with at least 60% porosity. Future 
studies could investigate the effect o f the impaction process on a graft formed from a 
mixture o f ApaPore and Actifuse with 60% porosity and even pure Actifuse with 
60% porosity. The results would provide a greater insight into how these variables 
affect the biological and mechanical response o f silicate-substituted hydroxyapatite.
There were limitations to the study described in Chapter 2, and any conclusions 
drawn from it need to take these into account. Firstly, although the primary ovine hip 
replacement model has been successfully used to investigate a revision scenario 
(Blom et al., 2005; McGee et al., 2004) there may be aspects of the tissue 
environment prior to revision hip surgery, in humans, that are not represented in this 
model i.e. endosteal erosions, residual inflammatory tissue and compromised host 
bone quality (Verdonschot et al., 2001). Secondly, there may have been discrepancies 
in the impaction grade between the different groups due to the effects o f variable
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particle size distribution and the reduced compressibility o f hydroxyapatite compared 
to allograft on the level o f impaction (Verdonschot et al., 2001). However, to 
minimise the disparity in impaction grade, all specimens were prepared and manually 
impacted by the same person.
As advances in m olecular biology are made, there has been a gradual move from a 
tissue approach to a more cellular approach in providing a more efficient means of 
reconstituting bone stock. Bone marrow contains a population o f cells capable o f 
differentiating into bone, cartilage, muscle, tendon, and other connective tissues. 
These mesenchymal stem cells (MSCs) have successfully been differentiated into 
osteoblasts, at our Institute. Furthermore, studies have shown that MSCs are able to 
survive the standard impaction forces encountered at revision hip surgery and their 
differentiating capacity does not appear to be reduced as a result o f the impaction 
process (Korda et al., 2006).
The work in chapter 3 o f this thesis exploited the use o f impaction grafting using a 
composite graft formed from the osteoconductive matrix o f allograft and/or granular 
HA combined with mesenchymal stem cells (MSCs), which provide osteoinductive 
and osteogenic properties. In this way, the allograft and/or HA acts as a delivery 
system and scaffold for the MSCs, allowing the passage o f osteoblast progenitor cells 
to the graft site and facilitating bony ingrowth. Results showed that the addition of 
MSCs to allograft alone or a 50:50 mixture o f allograft/granular HA by impaction 
grafting enhanced the amount o f new bone formation when compared with 
unimpacted constructs. An ovine metaphyseal femoral unicortical bone defect model 
was selected for this study and although this is a suitable model which simulates 
some o f the environmental characteristics encountered in revision hip arthroplasty, it
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does not mimic the loading conditions encountered clinically. Further work 
evaluating a composite graft composed o f allograft/HA seeded with MSCs in an 
ovine hemiarthroplasty model would provide valuable information as hip forces in 
sheep correlate well with those in humans (Bergmann et al., 1984). Thus, functional 
loading o f the graft-composite would be similar to that encountered in the clinical 
setting and would indicate whether this technology is transferable to humans.
In Chapter 3, a metaphyseal femoral condyle defect model was used to investigate the 
osseoinductive capacity o f  impacted TE constructs. Although this model has several 
advantages, the environment does not simulate the conditions encountered clinically 
during a revision situation where impaction grafting would be used. For example, this 
area has a good blood supply and does not mimic the poor bone stock encountered in 
a clinical revision situation. Furthermore, within the sheep condyle the environment is 
very conducive to bone formation and any effect that the stem cells would have had 
may have been masked. To rule out osteoconduction or periosteal bone formation 
(Bruder et al., 1998; Kon et al., 2000) as disturbing and overriding mechanisms o f 
bone formation, ectopic implantation sites have been used successfully to investigate 
the bone-form ing osseoinductive capacity o f tissue-engineered constructs implanted 
in goats (Kruyt et al., 2003). In Chapter 4 , 1 explored the hypothesis that the addition 
o f MSCs to allograft or HA granules would enhance the amount o f new bone 
formation when com pared with allograft or HA granules alone in an ectopic sheep 
model. An extra-skeletal model would indicate the osseoinductive nature o f the 
combined scaffold and stem cells and has the added benefit o f allowing the 
investigation o f many variables in one animal.
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Results showed that in both the impacted and un-impacted groups, there was more 
new bone formation when allograft was seeded with mesenchymal stem cells 
compared with allograft alone. Conversely, an impacted and un-impacted porous 
ApaPore scaffold, either alone or combined with mesenchymal cells, failed to 
produce any new bone ectopically in sheep. The low values o f bone formation 
observed, even in the best samples, were equivalent to amounts seen in another 
publication (Kruyt et al., 2003). These results have to be interpreted with some 
caution due to the small sample number.
My results are in direct contrast to those observed by Kon et al (2000) who showed 
that cells loaded onto porous HA scaffold conducted a far more extensive bone 
formation than cell free implants in tibial defects in sheep. However, there are several 
noticeable differences between their study and this one. Firstly, they used un- 
impacted cells. Secondly, they used an external fixator to achieve mechanical stability 
and this could potentially cause mechanical stimulation o f both implants and bone 
resected ends. Thirdly, they used fibrin as a cell sealant, which itself has been shown 
to promote osteogenesis from the host osteoprogenitor cells (Fortunato et al., 1997). 
Finally, the animals in their study were euthanased at 8 weeks whereas in my study 
they were sacrificed at 6 weeks. It could be speculated that more bone formation 
could have been observed in my study if  it was conducted over a longer period.
Another fundamental difference between the study by Kon et al (2000) and that 
described in Chapter 4, is that they investigated a scaffold consisting o f HA cylinders 
and not granules, as used in my study. It therefore appears that the morphology o f the 
scaffold is crucial in tissue engineering and this formed the basis o f Chapter 5. In this 
study, I investigated the potential o f the use o f a composite graft formed from blocks
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o f HA seeded with MSCs and demonstrated observable osteogenesis. This 
observation reflects the results o f the majority of studies that have assessed TE 
constructs with MSCs seeded onto blocks o f porous ceramic bone substitutes (Bruder 
et al., 1998; Kon et al., 2000; Kruyt et al., 2003). In fact, Ripamonti et al. (1991, 
1993, 1996) found bone induction only in block-shaped HA with cavities and failed 
to grow in identical porous hydroxyapatite in granular form. They referred to this 
morphologic prerequisite as geometric induction. It is possible that in block-shaped 
HA with cavities there occurs an accumulation o f factors that are needed for 
induction and/or differentiation o f cells (Yamasaki and Sakai, 1992). Furthermore, 
such a micro-environment may favour calcium phosphate dissolution and re­
precipitation, a mechanism postulated by some investigators (Kruyt et al., 2003; Yuan 
et al., 2002) to be responsible for bone induction. This induction theory may even be 
supported by the finding that osteogenesis inside arteriosclerotic plaques only 
occurred as a final stage, inside calcified (hydroxyapatite) plaques (Deneke et al., 
2001). In the context o f this thesis, this has major clinical implications as most o f the 
commercially available HA is produced in granular form and impaction grafting can 
not be performed with blocks o f hydroxyapatite.
Recently, the use o f bone morphogenic proteins (BMPs), in the treatment o f 
osteolysis has attracted much attention. BMPs are a family o f osteoinductive growth 
factors that can initiate endochondral bone formation, presumably by stimulating 
osteoblast progenitor cells, and by enhancing bone collagen synthesis. Recombinant 
human bone morphogenic protein-7 (BMP-7 or OP 1 ) has been shown to promote the 
incorporation o f morsellised allograft bone into new host bone in an animal model 
(Salkeld et al., 2001; Jensen et al., 2002) and has shown good results in treatment o f 
fracture non-unions and spinal fusion surgery in humans (Friedlaender, 2001; Sandhu
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and Boden, 1998). Initial reports of the use o f OP-1 in association with morsellised 
cancellous allograft to treat major bone loss during revision hip surgery have shown 
promising results (Cook et al., 2001). However, in a loaded bone grafting situation, 
OP-1 was not shown to promote the incorporation o f the graft bone into host bone in 
large animal studies (McGee et al., 2004; Buma et al., 2007; Jeppsson et al., 2003; 
Tagil et al., 2003). In humans, the addition o f OP-1 to morsellised allograft during 
impaction grafting has not been shown to improve the early fixation o f either the 
acetabulum or femoral component at a five year follow-up (Karrholm et al., 2006). 
The most likely explanation for these disappointing results is that although BMPs 
enhance new bone formation, they also accelerate bone resorption in the early phase 
after grafting (Jensen et al., 2002; Kaneko et al., 2000). It could be speculated that an 
impaired bone bed, as encountered during revision hip arthroplasty, changes the 
balance between bone formation and resorption towards the latter. Clearly, 
uncontrolled graft resorption in human femoral impaction grafting could lead to 
implant subsidence and loosening and therefore the use o f BMPs in impaction bone 
grafting can not be advocated at present.
These results confirm that the key to success with impaction grafting is to obtain 
sufficient primary stability o f the tissue engineering construct. In this thesis, the 
addition o f MSCs to an allograft or a 50:50 allograft:HA scaffold by impaction 
grafting enhanced the amount o f new bone formation when compared with 
unimpacted constructs, whereas an impacted ApaPore scaffold combined with MSCs 
failed to produce any new bone. It therefore appears that allograft provides stability 
for the MSCs to allow bone formation, but HA granules do not. One reason for the 
observed lack o f osteogenesis with HA granules could be due to micromotion 
between the individual granules and the adjacent bone interface. Micromotion has
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been shown to inhibit bone growth into porous biomaterials, leading to fibrous union 
(Cameron et al., 1973; Lindholm et al., 1994). For example, Snyders et al. (1993) 
evaluated the use o f negatively charged dextran beads with and without the use of 
calcium sulphate slurry as a binding agent in 5mm diameter calvarial defects in rat. 
The combination o f the two materials promoted better bony repair, whilst the dextran 
beads used alone produced mostly fibrous tissue with less bone in the wound than 
even the controls. The authors attributed the success o f the combined treatment to the 
binding effect o f the calcium sulphate and its ability, after setting both, to maintain 
the material at the site without movement and to retain the space, preventing soft 
tissue collapse into the wound area. Lindholm et al (1994) have also provided 
evidence o f poor osteoconductivity o f granular material in the calvarial model and 
demonstrated that motion o f HA granules initiated the formation o f inflammatory 
granulation tissue, which impeded new bone formation. These findings seem to 
suggest the need for sufficient stability o f implanted biomaterials during healing in 
order to allow for bone formation.
In conclusion, this thesis has demonstrated that HA is a suitable bone substitute to 
augment allograft and may be used to replace bone graft in impaction grafting of a 
femoral component. This has important clinical implications as it is readily available, 
easy to use in surgery and not associated with the adverse effects encountered with 
allografts. The use o f MSCs in the treatment o f osteolysis holds great potential, but 
further work is required to assess if  this technology is transferable to humans. If 
successful, it could have a substantial public health impact and would improve the 
functional results o f thousands o f patients undergoing revision joint arthroplasty.
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